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Abstract

THE EFFECTS OF OBESITY AND SURGICALLY-INDUCED WEIGHT LOSS ON
EXERCISE VENTILATION: INFLUENCE OF CENTRAL ADIPOSITY AND SERUM
LEPTIN
By Jeffrey E. Herrick, PhD
A Dissertation submitted in partial fulfillment of the requirements for the degree of
Doctorate of the Philosophy of Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director: Ronald K. Evans, PhD
Associate Professor, Department of Health and Human Performance

Truncal adiposity impairs ventilation in obese adults by altering normal ventilatory
mechanics. Leptin, an inflammatory adipocytokine, is elevated in obesity and has been
shown to alter ventilatory responses to exercise. Leptin’s bioavailability appears to be
regulated by its soluble receptor (LRe), which is reduced in obesity. Roux-en-Y gastric
bypass surgery (RYGBS) is a weight loss intervention that reduces total fat mass and
improves several obesity related co-morbidities including pulmonary dysfunction. The
purpose of this study was to first evaluate the differences between ventilatory responses to
carbon dioxide (VE/VCO2 slope) during progressive treadmill walking in morbidly obese
and normal weight females. Second, we will analyze the relationships between the
x

VE/VCO2 slope, truncal adiposity, serum leptin, and LRe. Lastly, we want to evaluate the
changes in the ventilatory responses to exercise (VE/VCO2 slope), truncal adiposity, serum
leptin, and LRe 3 months following Roux-en Y gastric bypass surgery.
Thirteen obese (OB 37.7 ±11.4 years, 42.0 ± 4.8 kg/m2) and 12 normal weight
females (NW 36.1 ±8.0 years, 22.8 ± 1.2 kg/m2) participated in this study. Blood samples
for measure of fasting serum leptin and soluble leptin receptor were obtained prior to
exercise. Cardiopulmonary variables were measured throughout exercise. Regional
adiposity was determined through dual energy x-ray absorptiometry.
Truncal adiposity was significantly greater in the obese group than the normal
weight group. Serum leptin was greater in the obese group while LRe was lower than the
normal weight group. The VE/VCO2 slopes were lower in obese group when compared to
the normal weight group. There were no significant group differences in maximal
ventilation, tidal volume or respiratory rate. Stepwise regression determined that truncal
adiposity accounted for 31.5% of variance in VE/VCO2 slope (R= 0.561, R2 =0.315, p =
0.004). At 3 months post-surgery we observed significant reductions in the obese group in
total percentages of fat, truncal adiposity, serum leptin. The soluble leptin receptor was
not changed at any measured time point following RYGBS. There were no changes in 3
months post-surgery VE/VCO2 slopes in the obese group.
Truncal adiposity, serum leptin and LRe were associated with reduced ventilatory
responses to weight bearing exercise (VE/VCO2 slope) in obese females when compared to
normal weight females. There were no differences between obese and normal weight
females in maximal minute ventilation, tidal volume or respiratory rate. This result
xi

suggests that differences in VE/VCO2 slopes may not be entirely from maximal pulmonary
capacity. Rather, the differences in VE/VCO2 slope may be attributed to truncal adiposity
and its positive relationship with leptin. Elevated leptin in the obese group may indicate a
state of central leptin resistance which has been shown to reduce the ventilatory responses
to exercise.
At 3 months post RYGBS significant reductions in total percent fat, serum leptin,
truncal adiposity and BMI were observed. However, despite improvement in fat mass and
serum leptin there were no changes in the VE/VCO2 slope and LRe at 3 months post
RYGBS. Therefore, it is possible that the improvements in body composition and leptin
following RYGBS were not sufficient to increase ventilation responses to weight bearing
exercise in obese females.
This document was prepared with a Dell Latitude D610® laptop with a Centrino
processor microchip. Word processing was performed using Microsoft Word 2000®,
tables and figures were produced in Microsoft Excel 2000®. Statistical analysis was
performed by SPSS® statistical software edition 17.0.
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Chapter 1 An Introduction to the Review of Literature

Introduction to a Review of Literature
The percentage of United States population diagnosed as being obese is growing
with over 30% of individuals across all generations above their recommended body fat
percentage.1 The high prevalence of obesity is commonly correlated with increased
incidences of cardiovascular, metabolic, psychological, biomechanical and pulmonary
diseases.1, 2 Either alone or in combination, obesity-related diseases significantly shortens
an individual’s life and reduce the overall number of healthy years.1
Obesity has been shown to have profound adverse effects on respiration.3
Respiratory mechanics, respiratory muscle strength and endurance, pulmonary gas
exchange, control of breathing, pulmonary function parameters and exercise capacity have
been shown to be negatively altered in obese adults. 3 Specifically, morbid obesity (BMI >
40 kg/m2) has been associated with impaired exercise ventilation; primarily a mismatch in
ventilatory responses to the dynamic metabolic needs for oxygen delivery and carbon
dioxide removal.4 The combination of upper body adiposity and a reduced central
ventilatory drive are central to the etiology of obesity-related exercise hypoventilation.5-7
Exercise hypoventilation is characterized by a blunted respiratory response to hypercapnia
and the retention of arterial carbon dioxide and diminished blood oxygen saturation. Not
every case of obesity experiences elevated arterial hypercapnia, instead blunted respiratory
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drive may reduce minute ventilation and subsequent exercise capacity. This review will
primarily focus on the current scientific literature related to the impact of obesity, truncal
adiposity, serum leptin, the soluble leptin receptor and ventilatory responses to exercise.

2

CHAPTER 2 Review of Literature

Obesity
Globally, the percentage of adults classified as overweight or obese has increased
annually.2 The concern over the rising trend in obesity stems from the strong link between
obesity and cardiopulmonary and metabolic diseases. In the coming years obesity-related
diseases are likely to continue to produce significant reductions in overall healthy life span
years, increases in premature death, and global increases in health care costs.1, 8
Obesity Classification
The varying degrees of obesity and adiposity are commonly classified by indirect
measures of body composition (e.g., percentages of fat tissue, lean tissue, mineral and
water) along with the body mass index (BMI). BMI is determined by dividing body
weight in kilograms by height in meters squared and is primarily utilized for determination
of an individual’s risk for obesity-related diseases. Utilizing BMI, the American College
of Sports Medicine (ACSM) categorizes males or females as obese with a BMI greater that
30 kg/m2, as morbidly obese with a BMI greater than 40 kg/m2 and as super obese with a
BMI greater 50 kg/m2. The BMI is the most common clinical measure utilized to
determine obesity in adults and is positively correlated with disease risk.1 ACSM also
classifies obesity in males and females as a percent body fat greater than 25% and greater
than 32%, respectively.
Body Composition Assessment
3

Numerous methods are utilized to determine the various combinations of the
primary components of body composition: fat mass, fat-free mass, total body mineral and
total body water. The utility of each body composition method is often dependent on the
setting and the level of reliability and validity required. Many assessment methods are
relatively inexpensive and require minimal time investment (e.g., skinfold measures and
bioelectrical impedance analysis) while other techniques require expensive equipment and
skilled professionals (e.g., dual x-ray absorptiometry (DXA) and hydrostatic weighing).
For decades hydrostatic weighing, a measure of whole body buoyancy and water
displacement during water immersion, was regarded as the most valid and reliable
technique for both clinical and research settings. More recently, hydrostatic weighing use
has declined as new technologies have emerged that have reduced the assessment time
while increasing the precision of the measurement. Presently, dual x-ray absorptiomitry
(DXA) is the most widely used in research and considered to be the gold standard for body
composition research. DXA utilizes a whole body x-ray source and detector scan to
estimate fat mass, fat free mass and bone mineral density. A recent study compared the
body assessment data of DXA to a four component model utilizing both obese male and
female adults. Their findings indicated that DXA produced a prediction error of ± 4.2%
body fat in both cohorts. Despite the potential measurement error, DXA remains one of
the most precise indirect measures of body composition available. An additional research
benefit of a DXA assessment is the ability to estimate tissue distributions throughout
various regions of the human body, thereby providing researchers with the ability to
evaluate disease risk in relation to fat distribution patterns.
4

Obesity and Weight Loss Surgery
Traditionally, reductions in adiposity and improvements in obesity-related comorbidities have been primarily sought with programs designed to increase physical
activity and reduce caloric intake. However, in many cases of chronic morbid obesity,
traditional weight loss interventions have been ineffective in producing sustainable longterm weight loss.9 In such circumstances, many morbidly obese adults, in consultation
with their physicians, have chosen to undergo surgical weight loss procedures to reduce
body mass, reverse obesity-related co-morbidities, and improve overall health.
Since 1998, the number of bariatric surgery procedures performed annually has
risen each year with nearly 80% of all patients being female.10 There are two techniques
that account for the majority of surgical weight loss procedures: 1) gastric banding, a
restrictive procedure used to reduce the amount of food entering the stomach, and 2)
gastric bypass surgery (GBS) which is both restrictive and malabsorptive as it also
bypasses a portion of the intestines. GBS accounts for 80% of reported bariatric
operations.10
Gastric Bypass Surgery
GBS was initially performed via an open laparotomy where one large transabdominal incision is made. While there have been several modifications to the original
laparotomy procedures to reduce the size of the incision and improve healing, recent
advances in surgical instrumentation have resulted in greater utilization of laparoscopic
techniques. Laparoscopic techniques use smaller incisions for surgical tools and a camera
that allows the surgeon to visualize the surgical field. The reported benefits of
5

laparoscopic gastric bypass surgery (LGBS) over traditional open GBS includes a shorter
post-operative recovery time, fewer revisions to repair leaks, tears and stretching of the
gastric pouch, reduced incidence of infection, quicker return to normal physical activity
and subsequent greater fitness outcomes, shorter hospital stays, and overall reduced
procedural cost. 9-11 GBS patients are typically cleared to commence an exercise program
within one month following surgery.10 For the individual, a reduced recovery time
promotes the initiation of a wide range of health focused activities such as lifestyle
physical activity and exercise. Likewise, for clinical research the rapid recovery
associated with RYGBS is beneficial for observation of metabolic, cardiovascular, and
pulmonary improvements. Thus, the rapid recovery time and significant overall
improvement in health support LGBS as the strongest procedure in measuring postsurgical outcomes in clinical research.
The most common LGBS procedure is the Roux-en-Y gastric bypass surgery
(RYGBS) which is malabsorptive and volume restricting.9, 12, 13 Briefly, the RYGBS
procedure consists of a division of the stomach into a small sized pouch and a bypass of a
portion of the large intestine.12 Overall, the objective of RYGBS is to modify both the
quantity of food that the stomach can digest while also reducing intestinal nutrient
absorption.
As a weight loss procedure, RYGBS is capable of producing rapid weight loss and
a near immediate improvement in several metabolic and cardiovascular risk factors.
Wittgrove et. al. conducted an extensive review of nearly 700 RYGBS patients and
observed post-operative weight loss at 6 and 12-month of 60 and 77% excess body
6

weight, respectively.12 Similarly impressive improvement in several common obesityrelated co-morbidities such as gastro-esophageal reflux disease (GERD), diabetes mellitus,
sleep apnea, hypertension and overall co-morbidities were reduced below clinical
parameters by 98%, 98%, 98%, 92% and 71% respectively.12 The rise in RYGBS
procedures in place of laparotomy and gastric banding techniques over the past decade
may be attributed to a rapid reversal of disease risk factors along with significant
reductions in total body mass.10 While the majority of research related to weight loss
surgery has been centered on the impact of various surgical, medical, and nutritional
patient outcomes in relation to changes in body composition, little research has
investigated the association between the post-surgical ventilatory improvements.
Blood Gas Concentrations
Cellular and pulmonary respiration is responsible for the expired and inspired
diffusion of oxygen and carbon dioxide gas from the atmosphere and the systemic
circuitry, respectively. At rest, the partial pressure of oxygen (PO2) and carbon dioxide
(PCO2) is fairly well maintained in most adults (described in Figure 1). The partial
pressure of a gas in a gas mixture is the independent pressure that the gas would produce if
it occupied the space in the blood alone. For instance, at sea level, room air consisting of
oxygen, carbon dioxide and nitrogen, has a partial pressure of 760 mmHg which is the sum
of its three main components: PO2 - 159 mmHg, PCO2 - 0.3 mmHg and PN2 - 601
mmHg.14
Fick’s law of diffusion describes how partial pressure gradients across tissues
produce diffusion gradients that subsequently drive the exchange of oxygen and carbon
7

dioxide during respiration.15 The diffusion gradients in the alveolus of the lung along with
the skeletal muscle arterial and venous capillary membranes drive the exchange of gases
(Figure 1).15 Further, Fick’s law describes that the flux in partial pressures on both sides of
a tissue’s membrane will drive the gas from an area of higher concentration to an area of
lower concentration. It is this principle that facilitates the cardiorespiratory system’s
ability to maintain relatively constant oxygen and carbon dioxide concentrations.
Lung (Alveolus)
PAO2= 105 mmHg
PACO2= 40 mmHg

Venous Blood
PAO2= 40 mmHg
PACO2= 46 mmHg

Arterial Blood
PAO2= 100 mmHg
PACO2= 40 mmHg

Muscle Capillary
PAO2= 40 mmHg
PACO2= 46 mmHg

Figure 1: Resting partial pressures of oxygen and carbon dioxide throughout the cardiopulmonary system.
Figure adapted from.14

Blood Gas Measurement
The most accurate measure of the partial pressure of oxygen and subsequent lung
diffusion capacity in the human body is obtained from arterial blood samples leaving the
heart. Likewise, obtaining a venous sample prior to blood entry in the heart would produce
an equally precise indication of metabolic carbon dioxide production during resting and
exercising conditions. This type of blood sampling, however, is not always possible as the
methods of sampling arterial blood with an inbound catheter is both potentially risky and
impractical in many research laboratories. Specifically, arterial blood sampling poses
8

significant risks and discomfort when utilized during weight bearing progressive exercise
protocols. To overcome the obvious challenges of the inbound arterial catheter, several
less invasive techniques have been developed to estimate arterial blood gas concentrations.
The first method is an “arterialized” blood sampling technique where the hand is
warmed through exposure to hot air, water or other warming device.16 The warming of the
surface of the hand will trigger an opening of subcutaneous capillary beds in an attempt to
cool the hand through conduction and radiation of redirected systemic blood. The opened
capillary beds provide an opportunity to sample mixed arterial and venous blood, a closer
representation of arterial gas concentrations when compared to venous samples alone.17
Extracted arterialized blood samples can then be quickly analyzed through a co-oximeter
blood gas system. A limitation of the arterialized blood gas sampling technique is that it is
an invasive assessment that may not always be available within an applied research setting.
Similar to an inbound arterial catheter, arterialized samples pose risk and are difficult to
employ with a weight bearing continuous exercise protocol.
Arterial gas partial pressures can be estimated non-invasively by measuring end-tidal
carbon dioxide (PETCO2) and oxygen (PETO2) partial pressures in expired air.18, 19 Endtidal refers to the volume of CO2 or O2 at the end of a breath and is reported in millimeters
of mercury (mmHg). The end-tidal gas measurement method has been shown to be within
±5% of arterial blood sample measurements at rest and during sub-maximal exercise.
During progressive exercise, end-tidal gas measurements were shown to slightly
underestimate CO2 partial pressures when compared to arterial gas samples.18 However,
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during maximal exercise, end tidal gas measures were shown to produce over and
underestimate of both oxygen and carbon dioxide tensions when compared to arterial
measurements. Despite the potential for error, end tidal gas measurement produce
acceptable estimates of partial pressures and allows for gas assessment during weight
bearing exercise protocols.
Resting Pulmonary Ventilation
The classical view of human ventilation (VE) theorized that a complex interaction
existed between several independent respiratory “centers” in the central nervous system 20.
It was believed that ventilation was initiated by a dense concentration of centrally located
independent rhythmogenic neural clusters collectively known as the medulla respiratory
center (MRC).14, 20 The MRC consisted of four independently functioning neural subgroups: the pnuemotaxic center, the apeneustic center, the inspiratory center (preBötzinger
complex) and the expiratory center (Bötzinger complex).14, 21 The lack of consistent
evidence supporting this theory of compartmentalized neural sub-groups led researchers to
theorize that respiration may be the product of a unified ventilatory drive. 21-24
Specifically, it was hypothesized that ventilation is a product of a single respiratory central
pattern generator (rCPG) or central rhythm generator.22 The rCPG functions automatically
and independently to drive basal VE via a diverse neuronal network in the MRC. The
rCPG produces a tonic ventilatory stimulus during basal conditions, however under
increased metabolic demand; the rCPG may be modulated by both voluntary actions and/or
chemosensitive afferent neurons. Specific locations of the neuronal networks are not
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entirely clear; however, it appears the locations commonly referred to the preBötzinger and
Bötzinger complex within the MRC produce the tonic neuronal impulses of rCPG
activity.21 The rCPG is described as being both tonically active and fully capable of
driving basal respiration independent of any central and peripheral feedback.22, 25 In
contrast, during changing metabolic conditions such a exercise, the rCPG is incapable to
respond to the complex array of both central and peripheral feedback.26 Thus, the rCPG
functions as the foundation of ventilatory drive and are easily modifiable by both voluntary
and involuntary stimuli. During exercise, the precise gain of the cardiopulmonary system
is highly dependent on central and peripheral chemoreceptor feedback modifying the rCPG
to metabolic requirements.27
Pulmonary Ventilation and Obesity
Obesity can significantly impair normal pulmonary function and places great stress
on the cardiopulmonary system. Increased adiposity alters normal pulmonary mechanics,
increases pulmonary resistance, increases work required for breathing, reduces lung
volumes, alters ventilatory drive and control and reduces exercise capacity.3 The following
section will attempt to describe the primary mechanisms that alter normal rest and exercise
ventilation.
Impaired Pulmonary Mechanics
Increased truncal adiposity produces an increased load for respiratory muscles to
overcome.3 The increased load was produced a 92% reduction in chest wall compliance in
morbidly obese adults when compared to predicted values.28 Likewise, reduced chest wall
11

compliance, lung compliance was also reduced by 25% of predicted values. A recent
review argued that despite the obvious relationship between greater trunk load and reduced
chest and lung compliance, the overall impact on inspiration is limited.3 Rather, the
increased truncal adiposity present a mass threshold with which inspiration must overcome
and which in most cases of obesity is easily compensated for. While it would appear that
increased truncal load is an important contributor to decreased chest wall compliance in
obese individuals, it does not appear to account for all of the observed impairment in
pulmonary mechanics.
Pulmonary Resistance
In comparison to normal weight subjects, obese individuals have been observed to
have an increased pulmonary resistance in the trachea, the bronchi and the chest wall.
Additionally, the magnitude of pulmonary resistance is positively correlated with BMI,
adiposity and the waist to hip ratio.3 The combined effects of one or all of the resistance
sites are often reported as an overall reduced lung volume.28, 29

Thus, reduced lung

volumes may alter gas exchange in the lungs and this occurrence may be magnified during
exercise.
Increased Work of Breathing and Reduced Lung Volumes
It would seem logical that the combination of reduced chest wall compliance and
an increased pulmonary resistance would result in an increased metabolic cost of breathing
in obese individuals. Likewise, increased chest wall adiposity and subsequent load should
require greater inspiratory muscle action and energy expenditure. However, several early
12

studies have demonstrated that this seemingly logical relationship is not always present in
obesity.30, 31 Kelly et al. demonstrated that when compared to normal weight adults (99%
of ideal body weight IBW), obese adults (183% IBW) exhibit greater reliance on chest
muscle action during inspiration coupled with a reduced reliance of diaphragm muscle
action.30 No significant differences in inspired airway pressure were observed between the
two groups, indicating that obese adults were able to compensate for decreased chest wall
compliance independent of greater inspiratory muscle force. In a earlier study, Sampson et
al. 31 observed that obese adults portioned their tidal volume to the chest wall rather than
the diaphragm thereby reducing reliance on abdominal action during inspiration. This
finding indicates that obese adults may compensate for reduced chest wall compliance and
increased abdominal load by altering the distribution of inspired air. In effect, if such
compensation exists, the viability of indirect circumference measures (i.e. abdominal girth,
WHR) as predication tools for potential ventilatory insufficiency may be inadequate.
Sampson et al. also observed a reduction in overall tidal volumes as a percentage excess
body mass above ideal body weight.31 Taken in total, these findings indicate that the
increased work of inspiration in obesity may be compensated for with increased inspiratory
muscle action and a reduced reliance on diaphragm muscle action.
Altered Ventilatory Drive in Obesity
Ventilatory drive is a measure of the rise in minute ventilation in response to an
increased metabolic demand. Impaired ventilatory drive is characterized by irregular
respiratory rhythms, shallow breaths that produce reduced tidal volumes, reduced response
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to hypercapnia (rise in PaCO2) and an overall mismatch in pulmonary response to varied
and progressive metabolic demands (reduced slope of VE/VCO2).40 Ventilatory drive is
commonly measured as the rise in minute ventilation (VE (L/min-1) to increased expired
carbon dioxide (VCO2). As described earlier, carbon dioxide is a potent stimulator of
central chemosensitive cells and functions to drive ventilation and increase the volume of
carbon dioxide expired (VCO2) to maintain PCO2 within normal limits. Simple linear
regression analysis of VE and VCO2 (VE/VCO2 slope) is the primary measure reported in
the scientific literature and has gained prominence as a measure of cardiovascular disease
risk.32
Though no clinical ranges have been established VE/VCO2 slope values in obese
subjects are often reported in the range of slope values near 17 to the low 23 while lean
adults are often 25 to 35.32 The VE/VCO2 slope is a product least squares linear regression
(y = a + bx; b = slope) from the beginning to the end of a progressive exercise protocol. A
fairly recent study determined that a VE/VCO2 slope produced from data encompassing an
entire exercise bout was a stronger predictor of pulmonary function that any segmented
form of the slope.32
In chronic obesity, the VE/VCO2 slope is a preferred assessment of cardiovascular
fitness and disease risk compared to traditional measures of maximal oxygen uptake
(VO2max), as the measure is not effort dependent.33, 34 Likewise, in pulmonary research the
VE/VCO2 slope is indicative of the combined ventilatory responses to meet the metabolic
demands of a progressive exercise bout. A recent study reported that VE/VCO2 slope was

14

a strong predictor of cardiorespiratory dysfunction that was not affected by VO2max and
BMI.35 Given the low relative VO2max, reduced exercise capacity, and potential for limited
exercise motivation in obesity, a marker of cardiopulmonary function independent of effort
is beneficial.
Reduced Exercise Tolerance
The combined obesity-related mechanical impairments and reduced central drive
produce an overall reduction in exercise capacity. 36-38 Generally it is has been
demonstrated that at rest, obese individuals consume approximately 25% more oxygen
than their non-obese counterparts.3 Likewise, during exercise, the increased body mass
may require greater oxygen consumption at matched workloads and vary between modes
of exercise. For example, during non-weight bearing cycle ergometry, percentage of
VO2max was not significantly different between different workloads when comparing obese
and normal weight adults.39 In contrast, treadmill walking produced a more pronounced
effect in obese subjects with lower respiratory rates and a reduce tidal volume compared to
normal weight adults.40
Exercise Ventilation
Exercise requires a fluid and rapid rise in respiration to facilitate increased gas
diffusion to match the metabolic demands of oxygen delivery and carbon dioxide
production23, 26 From the initial moments of physical activity and throughout an entire
exercise bout, the cardiopulmonary system must maintain the concentrations of arterial
blood gases at near resting levels (figure 1). The mechanisms involved in exercise blood
15

gas homeostasis during progressive exercise are not entirely clear; however, the following
review will attempt to present the generally accepted mechanisms responsible for
cardiopulmonary action and maintenance of systemic oxygen and carbon dioxide
concentrations during exercise.
Dynamics of Exercise Ventilation
At the onset of exercise, increased efferent neuronal activity of skeletal muscle
motor neurons traveling through the brain stem indirectly stimulate an increase in VE
above resting levels.25, 41 Likewise, the combined increase of central motor efferent and
proprioceptive afferent neuronal activity ascending through the brain stem, site of the
MRC rCPG, appears to co-stimulate the initial rise in VE .41 Evidence supporting the
indirect stimulation of VE was demonstrated in an exercise model when increased
respiration occurred prior to any central or peripheral humeral changes.41 This finding
substantiated early hypothesis that suggested that an increase in mechanoreceptor feedback
coupled with the efferent stream from the motor cortex appears to be the initial stimulators
of VE during progressive exercise independent of any humeral factors.42 Functionally, this
mechanism seems plausible as the uptake of O2 by cells for oxidative phosphorylation and
the accompanying systemic rise in metabolic CO2 and subsequent reduction in systemic pH
are not immediate with the onset of exercise Therefore, the motor and sensory activity
passing through the MRC could provide the indirect initial signal that increases ventilation
and pulmonary gas diffusion to accommodate metabolic demand.
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Several minutes into an exercise bout the peripheral chemoreceptors located in the
aortic bodies and carotid bodies provide critical humeral feedback to the rCPG and begin
modulating ventilatory rate.27 The peripheral chemoreceptors cells are predominately
excitable to alterations in the partial pressure of arterial oxygen (PaO2) and act as the
primary systemic oxygen sensors. Aortic chemoreceptors are excitable glomular cells that
exhibit an exponential increase in depolarization activity as PaO2 drops below resting
levels (<100 mmHg) although their role may be secondary to the carotid receptors.27
Carotid chemoreceptors are unique as their excitable cells have been shown to be sensitive
to both alteration in PaO2 and partial pressures of arterial carbon dioxide (PaCO2). Carotid
neuronal cells have shown a rapid and persistent increase in depolarization activity when
PaO2 drops below 100 mmHg.27 In a recent study it was demonstrated that carotid body
free nerve endings modified the rCPG with direct afferent action potentials in the MRC in
response to hypoxic conditions.25 The carotid chemosensors excitability to fluctuations in
PaO2 is several folds greater than the aortic body and is considered the primary peripheral
oxygen sensor.27 The excitability of the carotid bodies to hypercapnia (increased PaCO2)
has been demonstrated in several studies when PaCO2 exceed ~60 mmHg.25 The role of
carotid bodies during sea level hypercapnia is believed to be secondary to central CO2
chemosensors, however carotid bodies are believed to be essential for high altitude
acclimatization.
Central chemoreceptor neurons are located throughout the brainstem and are
sensitive to changes in the cerebral spinal fluid (CSF) concentrations of CO2, K+ and H+.22,
27

Central chemoreceptors have been observed as being highly concentrated in the ventral
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lateral medulla, solitary plexes, raphe, nucleus ambiguous, locus coeruleus, hypothalamus
and the hippocampus.27, 43 Stimulation of chemoreceptor free nerve endings produced
depolarizations that modulated the rCPG leading to a rise in ventilatory rate.27 Decreased
pH in the CSF will rapidly depolarize chemosensitive cells in the MRC and produce
increased magnitude tonic efferent bursts and increased respiratory rate.22 Hypercapnic
responses during exercise are primarily regulated by the chemosensitve neurons of the
central nervous system. As a result, Hypercapnia and subsequent central chemosensitivity
activity are viewed at the primary efferent drive to increase VE as exercise intensity
progresses.
Measurement of Exercise Ventilation
As previous described exercise ventilatory responses are often evaluated by
assessing the rise in VE to increased metabolic action (VE/VO2 slope), the rise in VE in
response to hypercapnia (VE/VCO2 slope) and calculated ventilatory and anaerobic
thresholds. Several studies have attempted to normalize exercise ventilation in relation to
overall aerobic work efficiency (∆VO2/ ∆Work), cardiac efficiency (∆HR/∆VO2) and
ventilatory responses to carbon dioxide (∆VE/∆VCO2) however these markers are intensity
dependent and subjective to individual effort.4 The following sections will attempt to
describe the primary methods for quantifying changes in ventilatory and metabolic
responses to exercise.
Ventilatory Threshold
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The ventilatory threshold (Tvent) is a point where the rise in VE in response to
increased VO2 progresses from a linear to an exponential rise.44, 45 Estimation of the
ventilatory threshold is accomplished by plotting VE over exercise during a progressive
exercise test.14 During progressive exercise, VE increases linearly up to approximately 5065% of VO2max depending on the individual’s cardiovascular fitness. Thereafter, VE will
increase exponential up to maximal VE. The primary stimulus for the exponential rise in
VE above Tvent is elusive, however several major contributors have been identified
including increased acidosis from rising levels of metabolic CO2, increased lactate
production and its associated H+, increased circulating potassium (K+) and increased
muscle fiber recruitment.23 The compensatory hyperventilation often observed above the
Tvent is stimulated via the central chemoreceptors and the increased PCO2, H+ and K+ in the
CNS.27 In a comprehensive review on chemoreceptors, it was stated that hypercapnia
stimulated central chemoreceptors produced the greatest stimulation to the MRC compared
to all other ventilation stimulation mechanisms.27 The resultant central action in normal
healthy adults is an exponential rise in ventilation and observed reductions in PaCO2 to
normative levels (~40 mmHg).
An impaired compensatory hyperventilation response has been described when
ventilation does not exponentially increase with rising PaCO2, eliminating the presence of
a Tvent .46 Although a complete understanding of the underlying mechanisms is unclear,
impaired chemosensitivity to CO2 has been described as a primary contributor.4 The
ventilatory responses to hypercapnia have been reported in healthy adults to produce a
slope rate of rise of 3 L/min/mmHg and in obese adults with normal ventilatory responses
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produce a slope rate of rise of 2 L/min/mmHg and in obese adults with a blunted
ventilatory responses produce a slope rate of rise of < 1 L/min/mmHg.46 The diminished
VE response to hypercapnia in obese adults is believed to be due to a blunted central
response resulting in an inadequate coupling of VE to VCO2. Obesity, genetic
predisposition and leptin resistance have been proposed as mechanisms that contribute to
the blunted hypercapnic response.46
Anaerobic Threshold
Similar to Tvent, the anaerobic threshold (AT) is another non-invasive method
utilized to assess the cardiopulmonary performance of an individual during a graded
exercise test (GXT).14, 47 Although the subject of vigorous debate, AT is a commonly
employed method for determination of the aerobic and anaerobic contributions during
progressive exercise. One method used to determine the AT is the V-slope method. The
V-slope method is utilized to determine the point at which there is a departure from
linearity when plotting VCO2 against VO2 during graded exercise.44 Wasserman describes
the AT as a product of an individual’s capacity to deliver oxygen to working muscles,
utilize mitochondrial aerobic metabolism, produce lactate, remove cellular lactate and
buffer metabolic CO2 through the bicarbonate buffering system.44 Further, the respiratory
gas concentrations during progressive exercise are determined by the coupled potential of
the cardiopulmonary and metabolic systems to respond to a changing systemic pH. In
obesity, the AT is an effective tool to describe the cardiopulmonary and metabolic
responses of an individual during progressive exercise. Typically, in obese adults, the
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presence of an AT occurs at a lower relative percentage of VO2max and HRmax when
compared to non-obese adults. The combined metabolic and cardiovascular impairments
of obesity contribute to an earlier onset and greater reliance on non-oxidative metabolism
during a graded exercise test.
Obesity-Related Impaired Exercise Ventilation
Morbid obesity has been demonstrated in both human and animal studies to be a
contributing factor to altered resting and exercising ventilatory responses to hypercapnia.36,
46, 48-50

Common symptoms of obesity-related impaired ventilation are low and irregular

respiratory rates, impaired ventilation response to hypercapnia and a subjective sense of
heavy breathing or dyspnea while at rest and exercise.38 Mechanisms that contribute to
obesity-related impairments in exercise ventilation generally fall into two primary areas; 1)
chest wall impairment and 2) an inhibited central drive.
Chest Wall Impairment
Chest wall impairment is a consequence of trunk bound adipose tissue which has
impedes normal muscular action of inspiration, increases the work of ventilation, reduces
tidal volumes and induces a more rapid ventilatory muscle fatigue.3, 37, 51, 52 In a recent
study investigating rapid weight loss following bariatric surgery, abdominal adiposity
height was assessed by the waist to hip ratio (WHR) and was demonstrated to be a stronger
predictor of impaired pulmonary function at rest than BMI.52 The authors concluded that
an increased WHR was associated with a minor ventilatory constraint and lung perfusion
which produced a larger difference between alveolar and arterial partial pressures of
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oxygen (∆(PA-a)O 2) along with PaO2. However, WHR ratio did not correlate with
impaired gas exchange in morbidly obese females. An alternate finding demonstrated that
adults with the highest BMI’s had the lowest level of impaired ventilation when compared
to non-obese controls.50 No specific mechanisms were theorized to account for their
equivocal findings. However, it could be concluded that mechanisms other than adipose
tissue airway obstruction and reduced chest wall compliance may contribute to obesityrelated impairments in exercise ventilation. Despite a consistent and even logical
relationship between impaired ventilation and trunk bound adipose tissue it is clear that
other mechanisms may contribute to impaired ventilation in obese individuals.
Obesity, Leptin and Impaired Ventilatory Drive
Inhibited central ventilatory drive is a complex mechanism and subject to multiple
interpretations. However, a growing volume of research has demonstrated that the
peripheral circulating factor, leptin, may in part regulate ventilation.5 Several animal and
human studies have demonstrated leptin’s central role as a ventilatory stimulant.5, 7, 53, 54 In
a knockout mouse model, leptin deficient mice when compared to wild type controls were
characterized as being obese, hyperphagic (excessive eating) and exhibited shallow and
irregular respiration. Direct leptin injections into the medulla respiratory center’s (MRC)
dorsal structures of the knockout mice produced a dose dependent rise in VE, VT and,
increased action potentials to inspiratory muscles.54 Likewise, in a similar study of leptin
knockout mice, direct leptin injections into the CNS rapidly improved VE independent of
any changes in adiposity.55 Human obesity is not commonly associated with leptin
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deficiency and reported cases of genetic deficiency are extremely rare.56 Rather, human
obesity is characterized by elevated serum leptin (hyperleptinemia) coupled with reduced
concentrations in the CSF.56 Therefore, it is assumed that obesity-related leptin resistance
in humans is a product of reduced BBB transport and the corresponding result may be
similar to leptin deficiency observed in animals.
In humans, hyperleptinemia has been positively correlated with the obesity
hypoventilation syndrome (OHS), disordered sleep ventilation and is a prognostic indicator
for congestive heart failure.34, 57, 58, 58 Obese adults with OHS, have an elevated daytime
PaCO2 ≥ 45 mmHg and a reduced chemosensitivity to CO2 which results in a diminished
ventilatory rate and volume. Obese adults with OHS have been shown to have greater
concentrations of serum leptin compared to age, gender and percent adipose tissue matched
non-OHS adults46; however, this study did not take measurements of CSF leptin
concentrations. The result is a corresponding rise in daytime hypercapnia in the absence of
a matched rise in VE.46 OHS presents many of the similar characteristics as an obesityrelated blunted ventilatory response to exercise.
Leptin association with impaired ventilation appears to primarily involve blunted
respiratory responses to hypercapnia but not to hypoxia. Leptin appears to modulate the
ventilatory responses to CO2 via direct stimulation of respiration via mechanisms in the
CNS.59, 60 Several sites within the CNS are believed to have chemosensitive cells;
however, our understanding of the contribution of each cluster of neurons is incomplete.
Recent evidence has demonstrated that a cluster of noradrenergic neuronal cells described
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as the locus coeruleus (LC) play a central role in hypercapnic responses to exercise.61 The
LC is comprised of several chemosensitive nuclei with nearly 80% of its neurons sensitive
to hypercapnia. Further, the LC accounts for nearly 50% of the noradrenergic projections
of the cardiovascular center.61 A recent study isolated the LC and demonstrated its
increased ventilatory activity during hypercapnia through acidic focal stimulation.
Likewise, destruction of the LC removed any ventilatory response to hypercapnia
independent of any other stimulus.61 These findings supported an earlier report that
chemosensitive neurons of the LC contributed to nearly half of the central hypercapnic
response in rats.62 Catecholaminergic neurons believed to exist within the brain stem were
shown to be primarily responsible for the central chemosensitivity. It was concluded that
noradrenergic neurons of the LC modulated hypercapnic responses during non-resting
conditions. These finding suggested that the LC might act as the primary sensor to CSF
CO2 during progressive exercise.
Leptin has recently been demonstrated to indirectly regulate central norepipherine
(NE) efflux by regulating gamma amniobityric acid (GABA) within the CNS.63 Leptin has
also been shown to both up regulate and down regulate GABA in a location dependent
manner. GABA is the predominant neuroinhibitor in the CNS and has been shown to
reduce NE action through pre-synaptic inhibition. A reduction in CSF leptin may produce
elevated GABA levels subsequently reducing NE efflux in the CNS. Reduced CNS efflux
from the hypothalamus and downstream locations may reduce the ventilatory response to
progressive exercise. In obesity, inhibited leptin transport into CNS may produce a leptin
deficiency and promote increased GABA synthesis. GABA is believed to inhibit NE via
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the GABAA receptor which is highly expressed in the hypothalamus and brain stem.63
Further research clarifying the role of Leptin, GABA, and ventilation responses to
hypercapnia is necessary.
In summary, impaired exercise ventilation in obesity may result from the combined
effects of reduced chest wall compliance from elevated concentrations of truncal adiposity
and a blunted central ventilatory drive. The combined effects of these two mechanisms
may be exacerbated during progressive exercise and reduce cardiovascular and ventilatory
efficiency. Figure 2 illustrates the proposed model of obesity-related impaired exercise
ventilation.

Morbid Obesity BMI > 40

↑ Truncal Adipose Tissue
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Increased Mechanical Load
Chest Wall Impediment
Impaired Exercise Ventilatory
CO2 Responses

↓slope VE/VCO2 (ventilatory response to carbon dioxide)

↓

Minute Ventilation
 Tidal Volume

Figure 2. Proposed model for altered ventilatory responses with obesity

Leptin and Obesity
Leptin was first discovered in 1994 and since has gained recognition as an essential
factor in several inflammatory conditions associated with obesity.64, 65 Leptin’s primary
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functions are diverse and involve several central and peripheral systems that regulate
appetite and energy homeostasis.66, 67 It has been hypothesized that leptin may function as
a single “master” biomarker for the progression of obesity and the subsequent risk for
related diseases.68, 69 Leptin’s central action appears to be appetite suppression in the
lateral hypothalamic area (LHA) by inhibition of neuropeptide-Y (NPY) and agoutirelated peptide (AgRP).70 Plasma leptin values are typically higher in obese compared to
non-obese adults when matched for age and gender and has commonly been shown to be
positively correlated with adiposity.71-73 Elevated levels of leptin are strongly correlated
with many obesity-related diseases such as hypertension, metabolic syndrome, immune
dysfunction, and chronic heart failure.69, 74
Chronic obesity is best viewed as a state of excess energy availability. Large
percentages of white adipose tissue (WAT) associated with obesity as an energy storage
depot that in most cases far exceeds the biological requirements of an individual. Oddly
enough, elevated leptin associated with obesity does not appear to inhibit eating
behavior.75 Current research has described the state of obesity as a chronic pattern of
endocrine dysfunction.6,8,67 Over the past decade several obesity linked cytokines have
gained recognition for their potential role as biomarkers for metabolic and cardiovascular
disease risk
Leptin Biology
Leptin was first observed over four decades ago in mice as an unnamed circulating
protein in plasma that appeared to play a role in regulating body weight.76 Initial
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observations suggested that when this protein was absent in the plasma it appeared to lead
to the progression of obesity in mice.76 It was not until 1994 that this protein factor was
cloned and described to the scientific community as leptin.64 From that 1994 study, Zhang
et al. identified leptin as an adipocyte secreted hormone that appeared to circulate in
proportion to the quantity of adipose tissue.64 It was theorized that leptin exerted both
satiety and metabolic stimulating actions in the hypothalamus affirming earlier
observations.64, 76 The discovery of leptin changed the way the scientific community
viewed adipose tissue and expanded our understanding of its role beyond caloric storage.
Indeed, adipose tissue is now considered the largest endocrine gland involved in regulating
many diverse essential cellular mechanisms.66, 77 Leptin’s primary role is in appetite
regulation; however it also appears to be a ventilatory stimulant.54
Leptin circulates in the serum in both a free or active form and bound to the soluble
leptin receptor (LRe) as an inactive or complex form.69 The free form of leptin is
attributable for the majority of its central and peripheral signaling actions. Leptin exerts
its intracellular effects via cell signaling cascades initiated through binding with the long
form receptor LRb.74, 78 The long form leptin receptor is highly concentrated in the central
nervous system and the primary binding cite for leptin.74
Leptin enters the CNS through binding with the leptin receptor LRa via endocytosis
with cells of the blood brain barrier.79 It is believed that leptin’s ventilatory role is
centrally located and its transport across the BBB is essential for its bioavailability.
Impaired leptin transport into the CNS is a central mechanism in the hyperleptinemia and
leptin resistance paradigm commonly reported in obese adults.79
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Leptin Synthesis and Secretion
Leptin is the product of the ob or also the lepr gene and is circulated in the plasma
with a molecular mass of 16 kDa with no known homologue amino acid sequence to any
other proteins.74 Leptin is secreted primarily through white adipose tissue (WAT);
however, synthesis and secretion has been observed in the gastric epithelium, brown
adipose tissue, skeletal muscle, liver, placenta and recently the brain.56, 80 Leptin secreted
from non-adipose peripheral sites are believed to serve a more autocrine or paracrine
function rather than endocrine.81 The local actions of non-WAT leptin secretion are
unknown. Leptin is secreted in a diurnal pattern that appears to follow the typical feeding
schedule of most humans.82 The lowest plasma levels are observed in the mid-morning
while the highest concentrations are typically after midnight.
Basal levels of total leptin in non-obese (BMI<30 kg/m2) subjects typically
circulates at concentration in the range of 5-15 ng/ml in both a free and carrier protein
bound form. In contrast, leptin has been observed in obese individuals (BMI > 30 kg/m2)
at concentrations over 200 ng/ml.74 No clear clinical plasma leptin guidelines have been
established for increased risk beyond commonly observed non-obese normative ranges.
Leptin Receptors
Leptin binds to six leptin receptors (LR) that belong to the cytokine class I receptor
family designated as LRa, LRb, LRc, LRd, LRe, and LRf, that are found commonly
throughout the body.74 All leptin receptor isoforms share the same extracellular binding
site indicating that active leptin is the only ligand. The primary differences between the
various isoforms is the protein structure of their carboxy-terminus intracellular domain,
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cell signaling cascades and the various tissue expressing each protein.74, 78, 83 The receptor
isoforms are also products of a single lepr (ob) gene and are individually expressed from
alternative mRNA splicing or proteolytic processing.84 Five of the six receptor isoforms
share the same transmembrane domains. The LRe, leptin’s soluble receptor, is the only
isoform that lacks both a transmembrane and intracellular domain.78
The highest expression of leptin receptors has been observed in the nuclei of the
hypothalamus.74, 78 The hypothalamic pathways and nuclei associated with leptin binding
act as the “dual center” of appetite regulation. The lateral hypothalamic area (LHA)
functions as the “hunger center” and the ventromedial hypothalamic region (VMN) as the
“satiety center”.70, 84 Leptin’s direct signaling action in the LHA and VMN is the origin of
acute and chronic energy intake and energy expenditure regulation.70, 85
Leptin Receptor Classification
Leptin receptors fall into there distinct classifications: secreted or soluble, short
and, long forms. The only secreted isoform is LRe (sometimes distinguished as LRs) and
it circulates as a soluble plasma bound leptin carrier.78 The soluble receptor LRe is cleaved
from the extracelluar domain of the membrane bound LRa and is believed to be the only
serum bound leptin carrier protein.86 Recent evidence has sited the importance of LRe for
the blood brain barrier (BBB) transport of leptin in the central nervous system.87 Using a
mouse model, Tu et al. observed reduced leptin cell surface binding to LRa and a
subsequent reduction in endocytotic transport into the CSF of mice exhibiting high
concentrations of LRe.87 Leptin and LRe bound complexes appear to be inactive with
reduced bioavailability and subsequent BBB transport. The importance of LRe
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concentrations may further extend our understanding of hyperleptinemia and leptin
resistance as observed in obese adults. The primary short form leptin receptor (LRa) plays
a key role in transporting leptin across the blood brain barrier into the cerebral spinal
fluid.79 Banks et al. described LRa function in an animal model where inhibited LRa
receptor expression at the BBB halted central activity of leptin. A subsequent direct
injection of leptin into the cerebral spinal fluid returned leptin activity to the hypothalamic
hunger centers.88 These findings indicated that altered LRa expression at the BBB may be
the central site for obesity-related leptin resistance. Treatments aimed at increasing BBB
LRa expression may represent a possible therapeutic intervention for obesity prevention.83
A further discussion on leptin resistance will follow later in this review. The role of the
remaining short form receptors (LRc, d, and f) remain unclear despite similar extracelluar
protein structure to the long form receptors.74, 78 The long form receptor, specifically LRb
is the most active and potent form and is the only receptor with intercellular signaling
pathways.78 LRb is highly expressed in a wide range of tissues such as brain, skeletal
muscle, liver, stomach, adipose tissue, blood vessels, lungs and kidneys. However the
greatest concentrations are observed in the nuclei of the LHA and VMN of the
hypothalamus.78 For example, hypothalamic LRb deficient mice tend to be obese,
hyperphagic, and do not respond to leptin infusion.89
LRb is the most significant of the receptor isoforms with the widest theorized roles
in appetite regulation and energy expenditure. Long form leptin receptors (LRb) have been
described as ubiquitously expressed on almost all tissues. The highest concentrations of
LRb are expressed in the nuclei of the “dual center” of the hypothalamus and appear to
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control food intake.75, 90 Other higher brain centers also express LRb signaling receptors in
the control of autonomic and neuroendocrine function.90 The LRb has been theorized as an
integral moderator for a wide range of leptin’s peripheral physiological mechanisms 81.
For instance, LRb expression in skeletal muscle appears to contribute to increased fatty
acid oxidation and cellular glucose and fatty acid uptake.91 Similarly, LRb is also highly
expressed in the kidney’s collecting ducts and is theorized to directly modify blood
osmolarity, blood pressure and mean arterial pressure.92 The prevalence of LRb expression
has demonstrated leptin as a seemingly “master hormone” involved in several
physiological mechanisms.81
Despite leptin’s influence on several biological mechanisms, not all receptor
signaling pathways are similar. An LRb intracellular signaling differential exists and is
dependent on the specific cell type expressing the receptor.93 The LRb associated with
skeletal muscle activates the AMP-activated protein kinase (AMPK) phosphorylation
cascade.94 Skeletal muscle expressing LRb has been shown to increase AMPK-dependent
beta oxidation and non-insulin glucose uptake.95 However, LRb expression within the
central nervous system functions through the janus kinase autophosphorylation and insulin
receptor substrate 1 and 2 signaling pathways.83, 96 Animal models have also demonstrated
leptin’s activation of several other signaling cascades such as: mitogen-activated protein
kinase (MAPk), extracellular signal-regulated kinase (ERK), Akt family of kinases and
phosphoinositide 3-kinase (PI3’) although their specific signaling actions are presently
unclear.93
Leptin, Appetite and Energy Balance
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The primary actions of leptin are often described as an anti-starvation hormone in
the regulation of appetite control. Leptin’s satiety actions have been described as a
“brake” on the bodies’ continual drive to take in nutrients.75 Konturek et al. described the
human appetite and homeostatic energy system as being geared toward constant weight
gain and the storage of calories and only a few mechanisms exist that actually encourages
weight loss.70 Konturek’s theory states that not until modern times has food been so
plentiful in the civilized world and as a result most individuals consume far more calories
than needed to sustain life. Likewise, the human’s innate drive to store energy has not
evolved with the modern feeding habits of today’s lifestyles.70 The result is the rapid
progression of human obesity and a corresponding state of biochemical confusion.
Leptin and Appetite Regulation
Leptin’s appetite regulatory actions in the “dual center” of the central nervous
system (CNS) are signaled via LRb in the lateral hypothalamic area (LHA) and ventral
medulla nuclei (VMN). Leptin exerts its action in the CNS through the cell signaling
mechanisms the janus kinase 2 (JAK2) and signal transducer and activator of transcription
3 (STAT3) and the insulin substrate receptor (IRS) protein and phosphatidylinositol 3kinase (PI3’-K) mechanisms.83, 93 Leptin’s inhibitory effects act on the LHA to decrease
the potent orexigenic (appetite stimulator) stimulators neuropeptide y (NPY) and agoutirelated peptide (AgRP) (figure 3). In contrast, leptin’s signaling in the VMN acts to
produce a sensation of satiation through the prohormone preopiomelanocortin (POMC)
along with the neurotransmitter peptide cocaine and amphetamine regulated transcript
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(CART) stimulation of the potent anorexigenic (appetite inhibitor) α- melanocyte
stimulating hormone (α-MSH). 83, 88
CNS: LHA/VMN
NPY ↓
AgRP ↓

↑ Satiety
Blood Brain Barrier
Endocytosis
Leptin Secreted in Blood

Adipose Tissue
Post Prandial Leptin Synthesis

Figure 3. Appetite regulation of leptin; adipose tissue synthesis, secretion into systemic
circulation, endocytosis with BBB, inhibit neuropeptide Y and agouti related peptide, and produce
satiety. 70

The process of acute appetite regulation is fairly complex; however, we are
convinced it begins with a meal. Post-prandial stomach distention is believed to trigger the
stomach’s mechanoreceptors that provide afferent signals to the CNS through the enteric
nervous system (ENS) of the gastrointestinal tract to inhibit the drive to eat.70 It is
believed that the ENS afferent signals via the vagal nerve have two primary functions.
First, the ENS functions to provide direct afferent feedback to the brain on the current
capacity of the stomach and in doing so co-regulate the drive “to fill or not fill”.70
Secondly, the ENS is believed to trigger the release of the gut peptide cholecystokinin
(CCK). CCK among its primary role in signaling pancreatic action and begin the process
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of gastric emptying is believed to stimulate leptin secretion. Both CCK and leptin initiate
the vagal nerve afferent signaling of stomach energy balance and begin the acute central
regulation of appetite.97, 98 Both leptin and CCK receptors have been observed along the
entire length of the vagal nerve.98
Cholecystokinin release appears to stimulate the synthesis of leptin from adipocytes
as both CCK and leptin secretion are increased both post-prandial and during infusion
studies.70 Like leptin, CCK also appears to inhibit the central drive to eat through similar
signaling pathways. CCK, similar to leptin, has been shown to directly inhibit in the LHA
the production of NPY and AgRP.85 The potential shared satiety action by CCK and leptin
in the hypothalamus is supported by similar cell signaling action through the JAK-STAT3
cell signaling mechanisms.81
Insulin is considered a primary mediator of leptin synthesis and secretion.99 For
example, following food ingestion the immediate pancreatic release of insulin is followed
by an acute elevation of plasma leptin.85 Research has further demonstrated that leptin
secretion may be stimulated indirectly by insulin-mediated glucose uptake and
metabolism.100 The up regulation of leptin via accelerated glucose metabolism has been
observed in both human and animal studies.100, 101 This relationship was further supported
within a mouse model where exogenous insulin injection produced a subsequent rise in
plasma leptin. It has been shown that post-prandial leptin and insulin are positively
correlated in both obese and non-obese adults.75 Interestingly, it was shown that leptin
levels were elevated following a high carbohydrate, low fat meal compared to high fat
meals.102 Further investigations have demonstrated that a carbohydrate-type dependent
34

response may exist. It had shown that consumption of high-fructose based meals initiated
a post-prandial rise in ghrelin and reduced leptin concentration.103 These responses would
fail to inhibit the drive to eat and may contribute to excessive caloric consumption. In
contrast, these effects were attenuated when glucose based meals were served.103 Muccioli
et al. cited these observations as potential contributors to overeating and increased caloric
storage. In a comprehensive review combined insulin and leptin responses are reduced
following fructose compared to other saccharide forms.104
Leptin’s Peripheral Actions
Leptin’s diverse endocrine effects have also been shown to alter several metabolic
functions in the pancreas, liver, skeletal muscle and the CNS.80 In non-obese individuals
the diverse peripheral actions of leptin generally contribute to the normalization of plasma
glucose and fatty acids. Leptin indirectly alters plasma fuel levels through increased
hepatic glucose production and reduce lipogenesis through increased lipolysis.80 Leptin’s
activation of hepatic lipolysis had been demonstrated in a mouse model with enlarged fatty
livers. Chronic leptin treatment reduced the overall liver size and lipid concentrations.105
Leptin’s direct action in the pancreas has not been confirmed. However, several
reviews site evidence of leptin’s potential role in improving insulin sensitivity.73, 105 In
leptin and insulin deficient mice, chronic leptin infusion decreased blood glucose,
glycosylated hemogloblin and circulating insulin levels.105 No clear mechanisms have
been discussed to explain the effect of leptin in improving insulin sensitivity.
Leptin’s chronic responses to homeostatic changes in energy balance are
fairly similar to its acute responses of appetite regulation. Both long and short term
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regulation follows the similar hypothalamic neuroendocrine pathway of the “dual center”
for appetite regulation. The over consumption of food far beyond necessary levels
stimulates the bodies mechanisms to store energy as white adipose tissue.70
Leptin Resistance
Lastly, the previously stated “leptin resistance” has garnered much interest over the
past decade with little understanding of its etiology.68 The correlation with
hyperleptinemia and adiposity has produced many theoretical mechanisms that contribute
to this state of leptin resistance and subsequent reduced hormonal action.
Early leptin resistance theories narrowed the potential resistant mechanism to the
BBB: specifically leptin’s inability to be transported across the BBB to the
hypothalamus.79 The leptin receptor LRa functions as the primary blood brain barrier
transporter protein and is found commonly throughout the cells of the BBB.78 Reduced
LRa BBB expression has been indicated as a potential contributor to reduced leptin action
in the hypothalamus.56, 79 Banks described leptin resistance as a mechanism of altered
BBB transport activity and subsequent reductions in CNS concentrations.79 Mechanisms
contributing to the decreased CSF levels of leptin are elusive; however, a relationship
between the ratio of the concentration of serum leptin to cerebral spinal fluid
concentrations is evident.46 In obese adults lower CSF concentrations (CSF/serum ratio
0.011  0.002) were observed when compared to lean adults (CSF/serum ratio 0.047 
0.01).106 This evidence suggested that despite elevated serum leptin levels, reduced leptin
transport across the BBB may be critical in the obese leptin resistant adult. Recent
research presented compelling evidence that in obesity, leptin BBB transport is greatly
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diminished and is associated with the soluble protein leptin transporter LRe.87 From these
findings it was suggested that LRe bound leptin appears to be unable to either bind with
LRa or activate endocytosis with the BBB or the combined complex inhibited LRa
expression entirely.87 Inhibited leptin transport across the BBB in humans may reduce the
CSF concentrations and mimic the responses observed in knockout mice models. The
recent findings would support the diminished CSF to serum leptin concentration ratios
observed by Caro et. al. over a decade ago.106 A graphical summary of the proposed model
of leptin resistance is depicted in figure 4.
Morbid Obesity
(BMI≥40 kg/m2)

Elevated Adipose Tissue

Leptin Synthesis
Serum Concentration

(+)

Hyperleptinemia

(+)

LRe; Bound Leptin

↓ Leptin Action (Resistance)

Figure 4. Proposed model of obesity linked basal hyperleptinemia and subsequent impaired central
leptin action.

In summary, leptin resistance in obesity is most likely: 1) an impaired BBB
transport mechanism antagonized by the bound leptin and soluble receptor complex’s
reduction of the bioactive form of the hormone, 2) a down regulation of BBB LRa activity
and reduced trafficking of leptin into the CNS, and 3) resistant or down regulated receptors
in the CNS.
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Leptin and Exercise
With leptin’s previously described relationship with obesity and its role in energy
homeostasis it is important to look at a possible interaction with exercise. The relationship
between an exercise effect and changes in circulating leptin are not so apparent as several
equivocal findings present opposing theories.107, 108 First, exercise has been suggested to
directly reduce leptin concentrations independent of either weight loss or caloric deficit.109111

Second, it has been shown that exercise does not reduce leptin independent of changes

in adiposity and energy balance.107, 108, 112, 113 The contrasting results are only complicated
further by the diverse research designs and data collection methods utilized to administer
the exercise interventions.111, 112, 114, 115 In a review of leptin and a possible exercise effect,
no consistent findings have been observed and the majority of the findings indicate there is
no direct effect of exercise on circulating leptin.107
The majority of findings that reported reduced leptin following exercise have
similar 24-48 hour post data collection time points. With the tight relationship between
leptin and acute nutritional state, isolating a chronic or long term exercise effect would
require long term post-exercise follow up. In a comprehensive review, it was suggested
that any investigations into an exercise specific effect may best be observed within a
caloric balanced and monitored model with data collection several days post.107 It has
been shown that acute changes in nutritional state (i.e. starvation, anorexia nervosa) can
lead to a rapid decrease in circulating leptin.116 However, in both of these conditions basal
leptin levels were returned to normal following feeding. Therefore, in order to observe a

38

chronic or even acute exercise effect independent of caloric deficit it may be necessary to
extend measurement beyond 24 and 48 hours post.
Exercise Regulating Leptin; Dependent on Energy Balance
The list of observed findings that indicated no direct leptin-exercise relationship is
extensive.108, 112, 117, 118 The majority of these studies have investigated an exercise effect
using models of matched energy balance, negative energy balance, short duration moderate
intensity, high intensity exercise, and program based long-term exercise interventions.119,
120

One of the earlier reports investigated a short term exercise intervention in healthy
young sedentary women.112 Hilton et al. employed an exercise intervention that consisted
of 4 days of several 30-minute treadmill bouts at 70% of VO2max or the caloric expenditure
equivalent of 30 kcal·kg·bw per day.112 From this study it was suggested that no
significant reduction in leptin occurred within the energy balanced sub-group that
consumed 45 kcal·kg·bw a day. However, within the same study, an energy deficient subgroup that consumed only 30 kcal·kg·bw did demonstrate reduced leptin following 4-days
of sub-maximal exercise. The study used rigorous control methods as both subjects were
sequestered for blood sample for 24 hours following exercise.112 The caloric cost of the
physical activity was estimated through accelerometers and meals were provided through
Ensure™, a commercially available liquid meal substitute. The findings indicated that
there was no leptin reducing exercise effect independent of caloric cost. A possible
consideration regarding these findings is that the model investigated healthy non-obese
women at a very low caloric cost exercise intervention. It could be possible that the
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combined overnight stays and reduced normal activity along with the moderate intensity
physical activity were still within the normal energy expenditure range of the subjects. If
this indeed was the case, the intervention was not extensive enough to disrupt energy
homeostasis in the energy balanced group. Indeed, several studies have demonstrated that
an exercise effect with matched energy balance may need to exceed 1000 calories.113
In a similar short term moderate intensity intervention, young lean males were
compared to older obese males.118 The intervention model consisted of 7 days of 60minute treadmill running at an estimated caloric cost of 450 kcals. Subjects were
instructed to follow their normal diet while adding an additional 450 calories to account for
the exercise intervention. No specific basal or exercise caloric assessments were
performed either pre or post-exercise. From this study, it was concluded that an
intervention of sub-maximal exercise with no changes in body mass and enhanced insulin
action does not reduce plasma leptin.118 The strength of this highly cited study is limited
in the lack of caloric control and precision in energy balance, limited exercise intensity and
heterogeneous groups.
In a more recent 7-month exercise intervention with obese young women, similar
findings were observed with the observed leptin reductions dependent on reduced fat
mass.120 Kondo’s model utilized a 7 month intervention of 4-5 days of 30-minute
minimum sub-maximal exercise. No attempts to control for energy balance were made and
groups were not stratified based on total weekly exercise time. From this study, a postexercise leptin reduction of 25% along with a decreased fat percentage of 14.1% was
observed.120 It was concluded that 7-months of exercise intervention did not reduce leptin
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independent of fat mass changes. These findings are not surprising since circulating leptin
is positively correlated with percent of total adipose tissue.66 Therefore, the findings may
be better suited to conclude that this intervention effectively reduced the percentage of
leptin producing tissue before any measured direct exercise effect.
Lastly, no reductions in plasma leptin was observed in obese males following a
short term sub-maximal exercise bout (58% of VO2max ).121 Total caloric energy cost was
estimated at 600 kcals per day and failed to induce any significant reductions in leptin.
Cumulatively, these studies have demonstrated the diverse approaches employed to
determine an acute and or chronic exercise effect at reducing leptin.
Exercise regulates Leptin: Direct Effect
The body of literature that has measured an exercise effect at lowering leptin
independent of weight loss, BMI and fat changes is limited. However, in a rigorously
controlled study that involved 4 different energy balance treatments, it was demonstrated
that moderate exercise with matched energy balance lowered post 48 hr plasma leptin.111
Additional findings from this study clarified many of the discrepancies observed in
previous research on leptin and exercise. One of the treatments investigated a no-exercise
state with a positive energy balance (calories beyond resting requirements) that produced
elevated plasma leptin levels.111
In contrast, another treatment in the same study matched exercise with a negative
energy balance, which produced the lowest circulating plasma leptin of all four
treatments.111 This finding demonstrated the rapid response of leptin to increase the
hunger drive within an acute state of exercise-induced energy deficit. It is clear from these
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findings that leptin, although sensitive enough to respond to acute changes in energy
balance may produce longer term changes with a matched caloric expenditure and intake.
Finally, this same study observed a 20% reduction in 24 hour leptin values with a
treatment of exercise expenditure matched to energy intake for energy balance.111 The
findings indicted that exercise may have a direct effect on adipose tissue secretion of leptin
and that the effect is manifested 24-48 hours post-exercise.
Two confirming studies had observed similarly delayed reduced leptin following a
single bout of exercise.122, 123 Within both models, a single bout of combined maximal and
endurance exercise that expended 800-1500 calories was tested. Both 24 and 48 hours
post-exercise leptin concentrations were reduced with the greatest reduction occurring at
48 hours post-exercise (30% and 40%, respectively).122, 123 Neither study measured
plasma leptin concentrations beyond 48 hours nor were unable to comment on the duration
of the exercise effect.122, 123
Lastly, in a study of obese sedentary males, significant reductions in leptin were
observed following 16 months of endurance exercise training.124 Strong negative
correlations were observed between leptin reduction and total hours per week of exercise
training along with improvement in cardiovascular fitness. Interestingly, reduced leptin
was not correlated with changes in percentage of body fat and insulin reductions despite
improvement in both.124
The effect exercise has on plasma leptin spans the entire range from no observed
independent change to a direct dependent change. However, a significant finding from the
existing body of literature is the importance of the research model used. For example, long
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term, low intensity, short duration exercise has shown leptin reducing effects.124 However,
similar exercise intensities during shorter treatment periods have measured no specific
leptin changes.117 It is possible that chronic changes of circulating leptin require time to
modify a “set point” of energy balance and thus require long-term exercise treatments. In
contrast, shorter acute exercise models may require a substantial caloric expenditure of 800
kcals or greater to modify post-exercise plasma leptin concentrations.
Summary
Obesity poses a global threat to the overall health of adults. Over the past decade
RYGBS has gained prominence as an intervention that rapidly reduces obesity-related
disease risk factors and excess body weight. In obesity, the combined impediment of high
concentrations of adipose tissue, coupled with systemic endocrine inflammation
significantly strains the biomechanical and physiological systems of the human body.
Specifically, these combined obesity-related mechanisms evidently impair both resting and
exercise pulmonary responses. It has been clearly shown that truncal adiposity
significantly reduces the overall mechanical function of the chest wall and the muscles of
inspiration and expiration.3 However, truncal adiposity alone does not appear to be the
primary factor associated with reduced pulmonary ventilatory responses during exercise.
On additional factor that has the potential to contribute to ventilatory impairments in obese
individuals is leptin. Leptin is found in high concentrations in the serum of obese adults
and several reports have shown correlations between the waist to hip ratio, body mass
index, total adiposity, and basal leptin concentrations and reduced pulmonary responses at
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rest and during non-weight bearing exercise.4, 5, 52 However, little research has investigated
the combined associations of leptin, and its soluble receptor along with total mass of
truncal adiposity and fat-free mass on cardiopulmonary response to weight bearing
exercise. Lastly, the effect of reducing truncal and total body fat and serum leptin on
exercise ventilation following RYGBS during an acute bout of weight-bearing exercise has
not been evaluated.
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CHAPTER 3 Manuscript One

Title: A comparison of VE/VCO2 slopes in normal weight and morbidly obese females: the
effect of truncal adiposity, serum leptin, and the soluble leptin receptor.
Abstract
Truncal adiposity impairs ventilation in obesity by altering normal ventilatory mechanics.
Leptin, an inflammatory adipocytokine, is elevated is obesity and alters exercise
ventilatory responses during exercise. Leptin appear to be regulated by its soluble receptor
(LRe), which is reduced in obesity. The purpose of this study was to investigate the
relationships between ventilatory responses to carbon dioxide (VE/VCO2 slope), truncal
adiposity, leptin, and LRe in morbidly obese and normal weight females during
progressive treadmill walking. Methods: Thirteen obese (OB 37.7 ±11.4 years, 42.0 ± 4.8
kg/m2) and 12 normal weight females (NW 36.1 ±8.0 years, 22.8 ± 1.2 kg/m2) participated
in this study. Blood samples for measure of fasting serum leptin and soluble leptin
receptor were obtained prior to exercise. Cardiopulmonary variables were measured
throughout exercise. Regional adiposity was determined via dual energy x-ray
absorptiometry. Results: Truncal adiposity was significantly greater in OB (OB 34.5 ±6.7
kg, NW 7.7 ±1.3 kg, p= 0.00). Serum leptin was greater in OB (OB 43.4 ±13.5 ng/ml, NW
9.04 ±3.9 ng/ml, p= 0.00) and LRe was lower in OB (OB 3.1 ±0.57 ng/ml, NW 5.4 ±1.1
ng/ml, p= 0.00). VE/VCO2 slopes were lower in OB (OB 22.48 ± 2.9 ng/ml, NW 25.7 ±2.5
ng/ml, p= 0.005). There were no significant group differences in ventilation, tidal volume
45

or respiratory rate. Stepwise regression determined that truncal adiposity accounted for the
31.5% of variance in VE/VCO2 slope (R= 0.561, R2 =0.315, p = 0.004). Conclusion:
Truncal adiposity, serum leptin and LRe were related to differences in ventilatory response
to exercise in normal weight and obese females.
Introduction
Obesity continues to be a major public health concern with nearly a third of all
Americans above their ideal body weight.1 Chronic obesity is linked to cardiopulmonary
and metabolic diseases, as well as certain forms of cancer.2 Obesity has also been shown
to alter cardiopulmonary responses to graded exercise with documented ventilatory
impairments that have the potential to impact activities of daily living and health-related
quality of life.3-5 Ventilatory impairments observed in obese subjects include a reduced
tidal volume (VT) and ventilation (VE L/min-1), and improved exercise ventilatory response
to carbon dioxide (VE/VCO2 slope). Much debate surrounds the specific mechanisms that
produce these ventilatory alterations; however it appears that a combination of elevated
truncal adiposity and reduced central chemosensitivity to carbon dioxide are the primary
mechanisms.
Increased truncal fat mass has been shown to reduce normal mechanical action and
compliance of the chest wall.6 Additionally, increased truncal adiposity results in
adipocyte infiltration of ventilatory muscles, reduced diaphragm muscle force, esophageal
confinement, increased pulmonary pressure and greater metabolic demand per breath.4, 6-10
Zavorsky et al. recently demonstrated that the waist to hip ratio (WHR), a common
measure of adipose tissue distribution, was associated with poor alveolar gas exchange at
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rest and proved to be a stronger predictor of ventilatory impairment than BMI or waist
circumference.25
In contrast to the physical impairments posed by truncal adiposity, recent evidence
from both human and animal studies suggests that the adipocytokine leptin may contribute
to obesity-related ventilatory impairments.11-13 Leptin’s central role as a regulator of
appetite and energy metabolism is well documented; however, leptin has also recently been
described as a ventilatory stimulant that appears to act upon central chemoreceptors.14 In
obesity, serum leptin levels are several fold greater than in normal weight adults, and
hyperleptinemia is associated with a reduced leptin action and a corresponding state of
leptin resistance as a result of a reduction in the soluble leptin receptor (LRe).15,16 While
the role of LRe is still not entirely clear, it has been shown to reduce leptin transport across
the blood brain barrier thus reducing leptin concentration in the cerebral spinal fluid
(CSF).17 A reduced CSF leptin concentration may exacerbate central leptin resistance and
contribute to obesity-related ventilatory impairments.18 In a recent study, elevated basal
leptin in obese subjects was associated with a blunted ventilatory response to hypercapnia
at rest.11 Furthermore, in an animal model, obese leptin deficient mice exhibited a reduced
respiratory drive, respiratory rate, tidal volume and diminished response to both hypoxia
and hypercapnia; all of which were reversed following direct injection of leptin into the
CNS.19
The VE/VCO2 slope is a common measure employed to assess the response of
ventilation to carbon dioxide production. The predictive strength of the VE/VCO2 slope on
cardiopulmonary function was first reported in heart failure patients where it was shown to
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not be limited by patient effort.20 Recent studies with obese adults have similarly
demonstrated that the VE/VCO2 slope is reduced when compared to normal weight controls
which suggest a blunted ventilatory response to carbon dioxide.21
The purpose of this study was to compare the ventilatory responses of morbidly
obese and normal weight females during an acute bout of weight-bearing exercise
(treadmill walking). Additionally, measures of truncal adiposity, serum leptin, and the
soluble leptin receptor were evaluated to further understand the factors that might
contribute to the obesity-related alterations in the ventilatory response to graded exercise.
We hypothesized that morbidly obese females would demonstrate a reduced VE/VCO2
slope in response to graded exercise compared to normal weight controls and that the
differences in the VE/VCO2 slope between the two groups would be related to increased
truncal adiposity, elevated basal serum leptin concentration, and decreased basal soluble
leptin receptor concentration.
Methods
Subjects
Normal weight (NW; BMI < 25 kg/m2) and morbidly obese (OB; BMI ≥ 40 kg/m2)
females were recruited to participate in this study. All subjects completed an informed
consent prior to participation in the study. All procedures were approved by the Virginia
Commonwealth University Institutional Review Board (Appendix A). Subjects were
required to visit the laboratory on one occasion between 7:00 – 8:00 AM after an 8 hour
fast. American College of Sports Medicine criteria for exercise testing and physician
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supervision were followed. Due to the increased level of risk, a cardiologist supervised all
graded exercise tests performed on morbidly obese individuals.
Anthropometrics
Height was measured to the nearest 0.5 cm using a fixed stadiometer and body
weight was determined to the nearest 0.5 kg using a digital scale. Abdominal, waist, and
hip circumference measures were assessed at standard anatomical locations to the nearest
0.5 cm.22 Waist to hip ratio and body mass index (kg/m2) were determined by standard
calculations.
Body Composition
Whole and regional quantities of adipose tissue and lean mass were obtained from
dual energy x-ray absorptiometry analysis (DXA; GE Lunar, iDXA, United Kingdom).
Truncal adiposity and lean tissue percentages (without bone mineral content) were
manually determined from iDXA software calculations based on the following
standardized anatomical sites: 1) upper body superior limits were the soft tissue boundary
of the shoulders excluding the neck and head, 2) lateral boundaries began at the
glenohumeral joints and continued along the soft tissue of the trunk with separation
between the arms, 3) the inferior boundary of the trunk was established from the most
superior point of the suprailiac crest.
Blood Analysis
A 7-ml resting blood sample was obtained via venapuncture from an antecubital
vein with a 21 gauge Vacutainer® blood collection set into a serum separator tube
(Vacutainer, BD Inc, Franklin Lakes, NJ). After 30 minutes at room temperature, the
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whole blood sample was centrifuged at 1000x g for 15 minutes. Following separation,
serum samples were aliquoted into sample tubes and frozen (-80° C) until later analysis.
Measurement of leptin and soluble leptin receptor weas performed using
Quantikine ELISA kits per manufacturer specifications (R&D Systems, Inc, Minneapolis,
MN). A microplate reader with an absorbance wavelength of 450 nm and automatic
correction wavelength of 540 nm (Bio-Rad 680 XR, Bio-Rad Laboratories, Hercules, CA)
was utilized to analyze all samples . Samples were run in duplicate and the intra assay
correlations of variation for each assay were averaged at 5.75% with all standard curve
correlation coefficients > 0.998. A single capillary blood sample was collected from the
finger 1-minute following exercise test termination for determination of maximal lactate
response (Lactate Scout, SensLab, Leipzig, Germany).
Cardiopulmonary Testing
Each subject was monitored with a 12-lead EKG during the graded exercise test.
Heart rate was obtained at the end of every minute and blood pressure and ratings of
perceived exertion (6-20 Borg scale) was obtained at the end of every stage. Continuous
breath by breath measurement of VO2 (L/min-1 & ml/kg/min-1), VCO2 (L/min-1), VE (STPD
L/min-1), VT (L/min-1), respiratory rate (breaths per minute), and RER (VCO2/ VO2) was
obtained during the exercise test (Vmax Encore, Sensormedics, Yorba Linda, CA). All
cardiorespiratory variables were averaged over 20 seconds for analysis. Maximal oxygen
consumption (VO2max L/min-1 & ml/kg/min-1) was determined as the highest 20 sec
averaged oxygen consumption value. Maximal lactate > 8.0 mM, maximal RPE > 18,
maximal RER > 1.15, and a maximal HR value within ± 10 beats per minute of age50

predicted maximal heart rate (220 – age) were used to assess subject effort during the
graded exercise test.
Morbidly obese subjects were monitored with a 12-lead EKG during the graded
exercise test. Heart rate response in normal weight subjects was determined with a heart
rate monitor (Polar Electro, Sweden).
Derived variables
The VE (STPD L/min-1)/VCO2 (L/min-1) slope was determined by least squares
linear regression (y = a + bx) with the 20 second averages from the entire exercise bout.
Statistical Analysis
Independent samples t-tests were utilized to analyze anthropometric and
cardiorespiratory variables between the two groups. Correlations between VE/VCO2 slope
and total and truncal adiposity, basal serum leptin, the soluble leptin receptor, and
cardiorespiratory fitness (VO2max) were performed with Pearson Product Moment
Correlations. Stepwise linear regression was used to analyze the prediction of the
independent variables leptin, LRe, and truncal adiposity on the dependent variable
ventilatory drive (VE/VCO2 slope). Significance was set with an alpha of p ≤ 0.05. All
statistical analyses were performed using SPSS 17.0 statistical software (SPSS Inc.,
Chicago, IL).
Results
Anthropometric measures
All anthropometric variables are provided in Table I. The obese group had
significantly greater total percent fat (OB 51.2 ± 4.4%, NW 29.9 ± 4.0 % p< 0.001), total
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body mass (OB 116.63 ±16.5 kg, NW 66.49 ±5.19 kg, p< 0.001), total trunk mass (OB
56.9 ±10.8 kg, NW 19.1±3.0 kg, p< 0.001 ), total truncal lean mass (OB 30.1 ±8.0 kg, NW
19.1 ±1.5 kg, p< 0.001), and truncal adiposity (OB 34.5 ±6.6 kg, NW 7.7 ±1.2kg, p<
0.001) than the normal weight group. Likewise, the obese group had significantly greater
abdominal, hip, and waist girth measurements and WHR. There were no significant age or
height differences between the two groups.
Cardiopulmonary Responses
Cardiopulmonary responses of the two groups to the graded exercise test are
provided in Table II. There were significant differences between the two groups in VO2max
(ml/kg/min-1), total exercise time, and VE/VCO2 slopes (Figure I).
Blood Markers
Serum leptin levels (Figure I, leptin OB 43.4 ±13.5, NW 9.04 ±3.9 ng/ml, p<
0.001) were significantly greater while soluble leptin receptor levels (Figure II), LRe OB
3.11 ±0.57, NW 5.37 ±1.13 ng/ml, p< 0.001) were significantly lower in the obese group
than in the lean group.
Correlations
VE/VCO2 slope was negatively correlated with serum concentrations of leptin (r = 0.483, p = 0.015) and positively correlated with the soluble leptin receptor (r = 0.470, p =
0.018). Similar positive correlations with VE/VCO2 slope were observed with truncal
adiposity (r = -0.562, p = 0.004), but not with truncal lean tissue mass (r = -0.299, p =
0.156). A negative correlation existed between VE/VCO2 slope and total body mass (r = 0.604, p = 0.001) BMI (r = -0.571, p = 0.003) and percent total adipose tissue (r = -0.631, p
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= 0.001). Surprisingly, there was no correlation with VE/VCO2 slope and the WHR (r = 0.136, p = 0.517). A relationship between VE/VCO2 slope was observed with total exercise
test time (r = 0.451, p = 0.024) but not with relative or absolute VO2max (r = 0.394, p =
0.052), Tvmax (r = -0.113, p = 0.592) or HRmax (r = 0.177, p = 0.399). Results from the
stepwise linear regression indicated that truncal adiposity alone accounted for 31.5% (r =
.561, r2 = .315, p = 0.004) of variance in ventilatory response to exercise. Our other
independent variables, leptin and LRe, were statistically excluded from the stepwise
analysis as they did not contribute any greater variance in the dependent variable than
truncal adiposity.
Discussion
To our knowledge, this is the first study to evaluate truncal adiposity, serum leptin,
soluble leptin receptor (LRe), and the VE/VCO2 slope during progressive weight bearing
exercise in morbidly obese and normal weight females. The VE/VCO2 slope was
significantly reduced in the obese group and truncal adiposity accounted for the greatest
variance in ventilatory responses to exercise between the two groups. Interestingly, there
were no significant differences between the groups in maximal minute ventilation,
respiratory rate and tidal volume suggesting that the differences in ventilatory responses to
exercise between the two groups were independent of mechanical limitations or altered
lung volumes.
We present for the first time that truncal adiposity accounted for nearly a third of
the variance in ventilatory responses to exercise, further expanding on the previously
reported relationship between total percent fat and reduced alveolar ventilation.23 In the
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majority of previous studies, truncal adiposity was indirectly measured as either the WHR
or as total fat percentage.24, 25 Both measures may fail to provide a direct indication of
truncal adiposity and may over and/or under estimate the potential impairment on exercise
ventilation.4, 9, 26 Analyzing exercise ventilation responses in relationship to a direct
measure of truncal adiposity as in this study may better explain the relationship between
increased chest mass and pulmonary mechanics.
A closer examination of the relationship between adiposity and ventilatory
response to exercise provided a few other findings. First, despite the significant correlation
between truncal adiposity and VE/VCO2 slope, there was relationship between truncal
adiposity and minute ventilation, respiratory rate or tidal volume. Further, there were no
significant differences between maximal ventilation, tidal volume and respiratory rate in
the obese and normal weight groups. This may indicate that mechanical limitations such
as chest wall compliance, inspiratory muscle force and reduced thoracic space were not
limiting factors in our obese cohort. This result is in contrast to a previous review that had
implicated truncal adiposity and obesity with reduced ventilatory rate and volume and
subsequent impaired alveolar gas exchange compared to normal weight controls.6 Our
results suggest that truncal adiposity modified the VE/VCO2 slope independent of any
direct mechanical impact on ventilatory volume and rate.
We observed that truncal adiposity and percent fat were both correlated with serum
leptin and LRe. This relationship may better describe the possible association between
truncal adiposity and the VE/VCO2 slope. This is a critical distinction as abdominal or
visceral adiposity is associated with greater secretion of pro-inflammatory cytokines (e.g.
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leptin).27 Therefore, in our cohort, truncal adiposity may alter VE/VCO2 slope indirectly
through increased leptin secretion into the blood stream.
Previous studies have reported a negative relationship between adiposity, serum
leptin and the VE/VCO2 slope during non-weight bearing cycle exercise.11, 24, 28 In our
study our subjects performed weight bearing exercise which has been shown to reduce
minute ventilation and tidal volumes when compared to non-weight bearing exercise.30 A
reduction in minute ventilation and tidal volume during weight bearing exercise places
greater strain on cardiopulmonary system to meet metabolic demands. Further, using a
weight bearing exercise model in research may better represent the normal daily activities
of obese adults and provide a better indication of the contributing mechanisms to
hypoventilation.
We are the first to demonstrate that reduced ventilatory responses in obese females
when compared to normal weight females during weight bearing exercise correlate with
reduced serum LRe concentrations. LRe has been described as a regulator of leptin’s
bioavailability through several reported mechanisms including reduction of leptin transport
into the central nervous system of mice.17, 29 In our obese group we observed reduced
serum LRe concentrations and elevated serum leptin, which suggests greater serum
concentrations of unbound leptin compared to our normal weight group.29 Based on the
mouse model, the lower serum LRe concentration in the obese group would further
indicate that leptin blood brain barrier transport was not impaired and that leptin was most
likely present in the cerebral spinal fluid (CSF).17 If leptin transport into the CSF was not a
limiting factor in our obese group than the reduced ventilatory responses in these subjects
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may reflect central leptin resistance. This idea is supported by our observation that the
VE/VCO2 slope was reduced in our obese group and by the observation of others that
central leptin resistance is related to elevated leptin and associated with reduced
chemosensitivity to hypercapnia and hypoventilation in obese adults.11 If this
interpretation is correct, our data also suggest the novel idea that reduced serum LRe in
human obese females may be an index of the presence of central leptin resistance leading
to reduced ventilatory responses. This raises the important question of whether low serum
LRe in obese subjects reflects low concentrations of central leptin receptors that are critical
for leptin's central actions.
We were also interested in the amount of variance that truncal adiposity, leptin, and
LRe accounted for in the VE/VCO2 slopes between the two groups. Stepwise linear
regression analysis revealed that truncal adiposity accounted for 31.5% of variance in
ventilatory responses to exercise. Leptin and LRe were statistically excluded from this
analysis indicating that their relationship with the VE/VCO2 slope did not contribute any
greater variance than truncal adiposity. Our findings further explain the relationship
between obesity, leptin, and ventilatory impairment by demonstrating that elevated truncal
adiposity can alter normal ventilatory responses to exercise.11, 13, 24 However the
ventilatory mechanisms altered by truncal adiposity appear to be independent of maximal
minute ventilation.
Several limitations must be considered when interpreting the results of our study.
First, we utilized VE/VCO2 slope as an indication of arterial gas concentration instead of
actual arterial blood gas sampling. Obtaining measurements of arterial concentrations of
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oxygen and carbon dioxide may further describe the difference in VE/VCO2 slopes
between the two groups. Additionally, we can only infer to the relationship in our study
between leptin, LRe, central chemosensors, and hypercapnia as it is not practical in human
research to obtain samples in cerebral spinal fluid. Our sample size may have been a
limiting factor and a larger cohort may have contributed to greater statistical power.
In conclusion, we observed significantly reduced VE/VCO2 slopes in morbidly
obese females during progressive weight bearing exercise when compared to normal
weight females. Truncal adiposity, serum leptin and soluble leptin receptor were all
correlated with a diminished VE/VCO2 slope, however truncal adiposity accounted for the
greatest variance in ventilatory responses to exercise. Despite their relationship with the
VE/VCO2 slope, both truncal adiposity and basal leptin were not correlated with minute
ventilation, respiratory rate, and tidal volume. This finding suggests that both truncal
adiposity and leptin altered ventilation independent of any mechanical impairment. In
contrast, the soluble leptin receptor was both related to the VE/VCO2 slope and with minute
ventilation. LRe was significantly reduced in the obese group indicating that leptin
transport in the central nervous system was not a limiting factor in exercise ventilation
responses. Rather, our obese group was leptin resistant and the resistance extended to the
cardiorespiratory center significantly reducing ventilatory responses to carbon dioxide.
We conclude that in obesity increased truncal adiposity, serum leptin and reduced serum
LRe are associated with impaired ventilatory responses to exercise.

57

Figures and Tables
Table I. Anthropometrics and blood markers between normal weight and obese groups.
Variable

OB
N=13
37.7 (±11.4)

P-value

Age (years)

NW
N=12
36.1 (±8.0)

Body weight (kg)

66.5 (±5.1)

116.6 (±16.5)

0.001*

Height (cm)

170.4 (±5.3)

166.2 (±6.5)

0.090

Body Mass Index (kg/m2)

22.8 (±1.2)

42.0 (±4.8)

0.001*

Abdominal Girth (cm)

81.3 (±4.5)

120.8 (±13.1)

0.001*

Waist Girth (cm)

73.2 (±3.2)

111.2 (±11.8)

0.001*

Hip Girth (cm)

101.0 (±3.8)

134.7 (±10.7)

0.002*

Waist:Hip Ratio

0.73 (±0.04)

0.83 (±.07)

0.050*

Total Percent Fat (%)

29.9 (±4.0)

51.2 (±4.4)

0.001*

Total Trunk Mass (kg)

19.1 (±3.0)

56.9 (±10.8)

0.001*

Truncal Fat Mass (kg)

7.7 (±1.3)

34.5 (±6.7)

0.001*

Truncal Lean Mass (kg)

19.1 (±1.5)

30.1 (±8.1)

0.001*

Total Leptin (ng/ml)

9.0 (±3.9)

43.4 (±13.5)

0.001*

LRe (ng/ml)

5.4 (±1.1)

3.1 (±0.5)

0.001

* Denotes significant difference (p ≤0.05) between normal weight and obese group.
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0.670

Table II. Cardiopulmonary responses to the exercise bout between the normal weight and
obese groups.
NW
N=12

OB
N=13

P -value

Total Exercise Duration (minutes)

21.5 (±1.6)

13.7 (±2.6)

0.001*

VO2max (L/min)

2.29 (±0.4)

2.46 (±0.4)

0.407

VO2max (ml/kg/min)

39.7 (±5.3)

21.4 (±4.3)

0.001*

VEmax (L/min)

66.7 (±11.6)

59.7 (±11.8)

0.134

Maximal Heart Rate (bt/min)

178.1 (±10.5)

170.2 (±16.3)

0.200

Maximal Respiratory Rate (b/min)

42.2 (±5.8)

40.7 (±5.9)

0.559

Maximal Lactate (mmol/L)

9.1 (±1.95)

6.8 (±1.87)

0.001*

19 (±1.0)

18 (±1.5)

0.788

VTmax (L/min)

2.07 (±0.3)

2.14 (±0.5)

0.784

VE/VCO2 slope

25.97 (±2.5)

22.28 (±2.9)

0.005*

Variable

Maximal Rating of Perceived Exertion

Data Presented as group means and standard deviations.
* Denotes significant difference between normal weight and obese group at p ≤0.05

Table III. Stepwise linear regression with truncal adiposity as predictor variables on the
dependent variable, ventilatory responses to exercise (VE/VCO2 Slope). Significance is set
at p≤ 0.05.
Dependent
Variable
VE/VCO2 slope

Predictor

R

R2

P=

SEE

Truncal Adiposity

.561

.315

0.004

2.80
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Figure I. VE/VCO2 slope during progressive treadmill exercise from the normal weight
group (NW) and the obese group (OB).
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* Significant difference (p≤ 0.05) between NW and OB groups.
Figure II. Fasting serum leptin concentrations prior to progressive treadmill exercise from
the normal weight group (NW) and the obese group (OB).
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Figure III. Fasting serum soluble leptin receptor (LRe) concentrations prior to progressive
treadmill exercise from the normal weight group (NW) and the obese group (OB).
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* Significant difference (p≤ 0.05) between NW and OB groups.
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CHAPTER 4 Manuscript Two

Title: The effects of Roux-en-Y gastric bypass surgery on the minute ventilation and
carbon dioxide slope in morbidly obese women: association of truncal adiposity, serum
leptin, and soluble leptin receptor.
Abstract
Background: Obesity is associated with increased truncal adiposity and endocrine
inflammation and both alter ventilation. Truncal adiposity impairs normal ventilatory
mechanics during exercise. Leptin is elevated in obesity and has been described as a
central ventilatory stimulant and its bioavailability is regulated by the soluble leptin
receptor (LRe) which is decreased in obesity. Roux-en-Y gastric bypass surgery (RYGBS)
is a weight loss intervention that improves body composition and several obesity related
co-morbidities including exercise pulmonary ventilation during non-weight bearing
exercise. The purpose of this study was to evaluate the effects of RYGBS on exercise
ventilation (VE/VCO2 slope) truncal adiposity, serum leptin, and LRe during weight
bearing exercise. Methods: Nine morbidly obese females participated in this study (37.7
±11.4 years, 42.0 ± 4.8 kg/m2). Cardiopulmonary variables were measured during
progressive treadmill walking prior to and 3 months following surgery. Fasting serum
leptin, LRe, and truncal adiposity were measured pre-surgery and 1 and 3 months post
surgery. Results: Significant reductions in total adiposity, truncal adiposity, and serum
leptin were observed at 1 and 3 months post RYGBS. There were no changes in LRe or
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VE/VCO2 slope at 3 months post RYGBS. Conclusion: Despite significant reductions in
truncal adiposity and serum leptin there were no improvements in ventilatory responses to
weight bearing exercise in morbidly obese females following RYGBS. It is possible that
weight loss and subsequent improvements in serum leptin and truncal adiposity were
insufficient to improve exercise ventilation during weight bearing exercise.
Introduction
Obesity is a major public health concern with nearly a third of all Americans above
their recommended body mass index (BMI).1 It has been well established that obesity is
associated with an increased risk for cardiopulmonary and metabolic diseases, as well as
some forms of cancer.2 In recent years, many Americans have sought treatment for obesity
and its related co-morbidities by electing to undergo weight loss surgery, including Rouxen-Y gastric bypass surgery (RYGBS).3 Reports have shown a steady increase in RYGBS
procedures since 2000 in both males and females.4 RYGBS is a mal-absorptive and
volume restricting surgery that produces up to ~70% of post surgical excess weight loss
and near complete reversal of many obesity related co-morbidities within the first year
following surgery.4 While the improvements in many co-morbid conditions have been
well documented following RYGBS, few studies have evaluated the effects of weight loss
following RYGBS on pulmonary ventilation.
Obesity has been shown to negatively impact both resting and exercising
ventilation and several mechanisms, including elevated truncal adiposity and reduced
central ventilatory drive, have been proposed to explain obesity-related pulmonary
impairments.5-7 Exercise requires a rapid and responsive alteration in ventilatory rate and
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volume to meet the changing metabolic demands from increased muscular activity. The
ventilatory response to exercise is often assessed by evaluating the slope of the rise in
minute ventilation to a corresponding rise in carbon dioxide (VE/VCO2 slope).8 The
VE/VCO2 slope indirectly quantifies the mechanical function of the lungs, chest wall, and
inspiratory muscles along with the sensitivity of the central respiratory centers to
hypercapnia. As a prognostic tool, the VE/VCO2 slope provides a valuable assessment of
cardiopulmonary responses to exercise as it is not dependent on individual effort.9 In
obesity, chemosensitivity to exercise-induced hypercapnia is often diminished and
ventilation fails to rise at a sufficient rate to maintain the desired work rate.10 This was
demonstrated in a recent study when weight loss surgery improved VE/VCO2 slope,
alveolar ventilation, and compensatory hyperventilation at 10 weeks following surgery.11
A recent study also observed that the waist to hip ratio (WHR), an indirect marker of
regional fat distribution, positively correlated with poor alveolar gas exchange.12 These
combined findings demonstrated a possible link between truncal and total adiposity and
ventilatory responses to exercise.
Recent evidence has indicated that adipose tissue induced mechanical impairments
are not the only possible mechanisms effecting normal resting and exercising ventilation.6
Several observations from both human and animal studies suggest that the inflammatory
adipokine leptin may play a central role in ventilation.13, 14 Leptin, a peptide hormone
secreted from adipose tissue, is primarily involved in appetite regulation and has been
shown to be elevated several fold in obese individuals compared to normal weight
controls.15 Hyperleptinemia is associated with a state of “leptin resistance” or reduced
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leptin action at the end organ binding site and is believed to affect cardiopulmonary
function.16
In a recent study, fasting leptin levels in obese subjects were associated with a
diminished respiratory drive and hypercapnic response that was independent of adiposity.13
Likewise, obese leptin deficient mice exhibit a reduced respiratory drive, respiratory rate,
tidal volume, and diminished response to both hypoxia and hypercapnia that is reversed
upon direct injection of leptin into the central nervous system (CNS).17 This suggests that
leptin may function either directly or indirectly as a ventilatory stimulant. A more recent
study determined that obese rats responded with dose-dependent improvements in resting
respiratory rate, rhythm and neural efferent signals following injections of leptin into the
dorsal structures of the respiratory center.14 Unlike obese leptin deficient mice, human
obesity is associated with high concentrations of serum leptin and reduced central action, a
condition commonly described as leptin resistance. In obesity, it is theorized that leptin
resistance must extend to the cardiorespiratory center altering normal ventilation.
Investigations into the potential mechanisms of leptin resistance suggest a link between the
soluble leptin receptor (LRe) and leptin transcytosis into the CNS which may inhibit leptin
transport across the blood brain barrier and contribute to reduced concentrations of leptin
in the cerebral spinal fluid (CSF).18, 19
The purpose of this study was to evaluate the effects of short-term (3-month)
weight loss following RYGBS on the ventilatory responses to progressive treadmill
walking in morbidly obese females. Additionally, measures of truncal adiposity, serum
leptin, and the soluble leptin receptor were evaluated at 1 month and 3 months post-surgery
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to further understand the factors that might contribute to improved ventilatory responses to
graded exercise following weight loss. We hypothesized that weight loss would result in
improved VE/VCO2 slope and the changes would be associated with decreased truncal
adiposity, reduced basal serum leptin concentration, and increased basal soluble leptin
receptor concentration.
Methods
Study Population
Female subjects were recruited through Virginia Commonwealth University’s
(VCU) Surgical Weight Loss Center. All subjects completed an informed consent prior to
voluntary participation. The study protocol was approved by the VCU’s Institutional
Review Board. To be included in the study subjects had to 1) be female, 2) have a BMI >
40 kg/m2 or a BMI >35 kg/m2 with two or more co-morbidities, 3) be able to walk
unassisted, 4) be scheduled to undergo laparoscopic Roux-en-Y gastric bypass surgery
(RYGBS) at VCU Medical Center, and 5) be cleared by a cardiologist to undergo maximal
exercise testing. Based on these criteria, 14 morbidly obese female RYGBS patients
enrolled in the study. Subjects were required to visit the VCU General Clinical Research
Center on three separate occasions: 1) Pre-surgical visit within two weeks of their
RYGBS, 2) 1-month post-surgery and 3) 3-months post-surgery. During the 1-month postsurgical visit, only anthropometric measurements and resting blood samples were obtained
as patients were not medically cleared for maximal exercise. Subjects reported for each
visit between the hours of 7:00 – 8:00 AM following and 8-hour fast.
Anthropometrics
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During each visit, height was measured to the nearest 0.5 cm using a fixed
stadiometer and body weight was determined to the nearest 0.5 kg using a digital scale.
Abdominal, waist, and hip circumference measures were assessed at standard anatomical
locations to the nearest 0.5 cm.20 Waist to hip ratio and body mass index (kg/m2) values
were determined by standard calculations.
Body Composition
Whole and regional quantities of adipose tissue and lean mass were obtained from
dual energy x-ray absorptiometry analysis (DXA; GE Lunar, iDXA, United Kingdom).
Truncal adiposity and lean tissue percentages (without bone mineral content) were
manually determined from iDXA software calculations based on the following
standardized anatomical sites: 1) upper body superior limits were the soft tissue boundary
of the shoulders excluding the neck and head, 2) lateral boundaries began at the
glenohumeral joints and continued along the soft tissue of the trunk with separation
between the arms, 3) the inferior boundary of the trunk was established from the most
superior point of the suprailiac crest.
Blood Analysis
A 7-ml resting blood sample was obtained via venapuncture from an antecubital
vein with a 21 gauge Vacutainer® blood collection set into a serum separator tube
(Vacutainer, BD Inc, Franklin Lakes, NJ). After 30 minutes at room temperature, the
whole blood sample was centrifuged at 1000x g for 15 minutes. Following separation,
serum samples were aliquoted into sample tubes and frozen (-80° C) until later analysis.
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Measurement of leptin and soluble leptin receptor were performed using
Quantikine ELISA kits per manufacturer specifications (R&D Systems, Inc, Minneapolis,
MN). A microplate reader with an absorbance wavelength of 450 nm and automatic
correction wavelength of 540 nm (Bio-Rad 680 XR, Bio-Rad Laboratories, Hercules, CA)
was utilized to analyze all samples. Samples were run in duplicate and the intra assay
correlations of variation for each assay were averaged at 5.75% with all standard curve
correlation coefficients > 0.998. A single capillary blood sample was collected from the
finger 1-minute following exercise test termination for determination of maximal lactate
response (Lactate Scout handheld analyzer SensLab, Leipzig, Germany).
Cardiopulmonary Testing
Subjects performed a progressive maximal treadmill walking test until volitional
fatigue. The treadmill protocol consisted of a 4 minute warm up at 2.0 MPH at 0% grade
followed by 2 minute stages at 2.5 MPH at 0% grade and 3.0 MPH at 0% grade.
Subsequent 2 minute stages maintained 3.0 MPH and increased grade by 2.5% every 2
minutes until the subject was no longer able to maintain the treadmill pace.
Each subject was monitored with a 12-lead EKG during the graded exercise test.
Heart rate was obtained at the end of every minute and blood pressure and ratings of
perceived exertion (6-20 Borg scale) was obtained at the end of every stage. Continuous
breath by breath measurement of VO2 (L/min-1 & ml/kg/min-1), VCO2 (L/min-1), VE (STPD
L/min-1), VT (L/min-1), respiratory rate (breaths per minute), and RER (VCO2/ VO2) was
obtained during the exercise test (Vmax Encore, Sensormedics, Yorba Linda, CA). All
cardiorespiratory variables were averaged over 20 seconds for analysis. Maximal oxygen
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consumption (VO2max L/min-1 & ml/kg/min-1) was determined as the highest 20 sec
averaged oxygen consumption value. Maximal lactate > 8.0 mM, maximal RPE > 18,
maximal RER > 1.15, and a maximal HR value within ± 10 beats per minute of agepredicted maximal heart rate (220 – age) were used to assess subject effort during the
graded exercise test.
Derived variables
The VE (STPD L/min-1)/VCO2 (L/min-1) slope was determined by least squares
linear regression (y = a + bx) with 20 second averages from the entire exercise bout.
Changes in truncal adiposity, leptin and LRe were determined as the difference between 3
month and pre values. Maximal oxygen uptake relative to fat free mass was calculated as
the absolute VO2 multiplied by 1000 and divided by the total lean mass in kilograms.
Statistical Analysis
Analysis for differences between pre, 1 month and 3 months post-surgery
anthropometrics and blood markers were performed using a repeated measures analysis of
variance. Post hoc analysis was performed using Tukey’s HSD. Determination of of presurgery and 3 month post-surgery difference in exercise variables were performed with
paired samples T-test. Person Product Moment correlations were utilized to evaluate
relationships among truncal adiposity, leptin, LRe, and cardiorespiratory variables.
Statistical significance was set at a p ≤ 0.05. All statistical analyses were performed using
SPSS 17.0 statistical software (SPSS Inc., Chicago, IL).
Results
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Fourteen morbidly obese females (37.7 ±11.4 years, 42.1 ±4.8 kg/m2) enrolled in
the study. One subject was not included in the final analyses due to failure to reach any of
the required criteria for a maximal exercise test. Four additional subjects did not perform
their 1 month and 3 month post-surgery trials due to scheduling conflicts, reducing the
final sample size to 9 subjects. All results are reported as mean (± SD).
Anthropometrics
Changes in anthropometric variables following gastric bypass surgery are provided
in Table I. At 1-month post-surgery, there was a significant decrease in BMI (p= 0.006 )
and total body fat percentage (p< 0.001); however, there were no significant decreases in
body mass, truncal fat mass, or waist to hip ratio. At 3 months post-surgery significant
differences were observed in total body mass (p = 0.005), waist (p= 0.01) hip (p= 0.002),
and abdominal (p= 0.049) circumferences, truncal adiposity (p= 0.006), and truncal lean
tissue mass (p= 0.023).
Leptin and soluble leptin receptor
Compared to pre-surgical values, leptin was significantly reduced at both 1 month
(Pre 38.8 ±7.5, 1 month 28.8 ±12.1 ng/ml, p= 0.03) and 3 months post-surgery (Pre 38.8
±7.5, 3 month 21.8 ±12.2 ng/ml p = 0.003) (Figure I). There were no differences between
1 and 3 month serum leptin concentrations. There were no significant differences in the
concentration of soluble leptin receptor across time (Figure II).
Cardiopulmonary Responses
Cardiopulmonary variables obtained prior to surgery and at 3 months post-surgery
are provided in Table II. There were no significant differences in VE/VCO2 slopes (p=
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0.70), maximal respiratory exchange ratio (p= 0.13), relative (p= 0.18) and absolute (p=
0.07) peak oxygen uptake, maximal oxygen uptake relative to fat free mass (p= 0.632),
maximal heart rate (p= 0.73) maximal minute ventilation (p= 0.20), maximal tidal volume
(p= 0.57) or respiratory rate (p= 0.19).
Person Product Moment Correlations
Pre- surgery leptin was correlated with BMI (r=.689 p= 0.009), abdominal
circumference (r=.609 p= 0.02), and truncal adiposity (r=.647 p= 0.01). Pre-surgery
truncal adiposity was correlated with BMI (r=.830 p= 0.000), and abdominal
circumference (r=.863 p< 0.001). At 1 month post-surgery leptin was correlated with BMI
(r=.656 p= 0.04), waist circumference (r=.732 p= 0.01), and truncal adiposity (r=.711 p=
0.02). One month truncal adiposity was correlated with waist circumference (r=.778 p=
0.008) and abdominal circumference (r=.780 p= 0.008). Pre-surgery, 1 month and 3
months post serum LRe was not correlated with any measured cardiorespiratory variable of
intent. There were no significant correlations between changes in leptin (r= .486 p= 0.18),
soluble leptin receptor (r=-.157, p= 0.68), and truncal fat mass (r= -.132, p= 0.73) and
VE/VCO2 slope at 3 months post-surgery.
Discussion
This study evaluated post-surgical changes in truncal adiposity, basal serum leptin
and the soluble leptin receptor, and ventilatory responses during weight bearing exercise.
Several recent studies have observed that both chest wall impairment from adipose tissue
and blunted ventilatory responses to hypercapnia alter ventilation in obese adults.7, 13
Several previous reports have evaluated obesity related ventilatory impairments during
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non-weight bearing cycle exercise.11, 13 In contrast, this study aimed to evaluate ventilatory
responses following RYGBS during weight bearing exercise. Despite significant
reductions in leptin and truncal fat mass 3 months post-surgery, ventilatory responses to
carbon dioxide, as assessed by the VE/VCO2 slope, were not improved during treadmill
walking. Additionally, soluble leptin receptor, which is thought to influence blood brain
barrier transport of leptin, was not significantly increased 3-months post-surgery.
Furthermore, we observed no relationships between the change in VE/VCO2 slope and
reduction in truncal fat mass, basal serum leptin, or LRe at 3 months post-surgery.
Our findings are in contrast to a recent study that observed that a 21 kg (16%)
reduction of total body mass improved pulmonary gas exchange, compensatory
hyperventilation and VE/VCO2 slope at 10 weeks following gastric bypass surgery.11 We
observed a 23 kg (24%) reduction of total body mass and nearly 5 kg of truncal adiposity
reductions that did not alter the VE/VCO2 slope. The differences between our findings and
previous reports may be our group experienced no improvements in tidal volume, minute
ventilation or respiratory rate at 3 months post surgery (Figure 3). Zavorsky et al. reported
significantly improved tidal volumes at 10 weeks post surgery, which may account for the
subsequent improved alveolar gas diffusion and compensatory hyperventilation. We
observed no significant difference in tidal volume within our group. It is possible that
gender difference may have contributed partly to our lack of agreement. In the Zavorsky et
al. report, 26% of their subjects were males, which have been reported to have poorer
alveolar gas exchange than females and thus may have benefited the greatest from post
surgery improvement in truncal adiposity.11, 12 Lastly, we utilized a weight-bearing
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exercise protocol which may exacerbate ventilation impairments to a greater extent that
non-weight bearing exercise.
Several reports have implicated hyperleptinemia as an indication of reduced
chemosensitivity to hypercapnia during exercise in obese adults.6, 13 Rising hypercapnia is
a primary stimulus that drives ventilation during exercise and subsequent reductions in
sensitivity may alter reduce ventilatory responses to exercise (VE/VCO2 slope).9, 21 In
obesity, elevated basal leptin is associated with blunted hypercapnic response and elevated
partial pressures of arterial carbon dioxide at rest and during exercise.13, 17 We observed
significantly reduced serum leptin levels of 26% at 1 month post surgery and nearly 44% at
3 months post surgery. Reductions in leptin were associated with decreases in total
adiposity, truncal adiposity and body mass index. However, there were no improvements
in 3 month post surgery VE/VCO2 slopes despite changes in leptin. Previous reports
showing improvements in respiration following reductions in serum leptin also reported
subsequent improvements in respiratory rate and tidal volume.14 We observed no
improvement in any ventilation marker despite significant reductions in serum leptin.
Therefore, it is possible, that in our cohort, at 3 months post surgery the observed fat mass
and leptin reductions were not sufficient to improve exercise ventilation. This suggests
that 3 months post RYGBS may have been too soon to observe any pulmonary changes as
a result of the reductions in fat mass and leptin concentrations. A previous report observed
the greatest median improvements in resting arterial gas partial pressures, lung volumes
and inspiratory and expiratory function were at 26 months post surgery.24 Suggesting that
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in our group a greater post-operative time was required to measure any significant
improvements in ventilatory responses to exercise.
We were also interested in the changes in the soluble leptin receptor (LRe)
following RYGBS. LRe is reduced in obese adults in comparison to normal weight
controls and this condition is reversed in obese individuals during severe caloric
restriction.22 Previous studies have suggested that LRe regulates leptin transport across the
blood brain barrier and a reduction in LRe contributes to obesity-related leptin resistance.19
In our subjects, LRe did not change at either post-surgical time points, suggesting that even
a fairly rapid weight loss of 21 kg in the first 3-month after RYGBS was not sufficient to
reverse the obesity-related reductions in LRe. Our results are surprising as RYGBS is both
a mal-absorptive and volume restricting surgery that significantly alters the daily caloric
intake of the patient to 800-1000 calories per day. LRe concentrations in females with
anorexia nervosa and following 3 weeks of very low calorie diets of 550 calories (VLCD)
have been previously evaluated.22, 23 Increased levels of LRe were observed in anorexic
females when compared to normal weight controls. Likewise, increased LRe was observed
in obese adults following 3 weeks of a VLCD when compared to control subjects. These
combined findings indicate that with nutritional deficit LRe synthesis appears to be up
regulated. Similarly, RYGBS produces weight loss through a significant caloric deficit
that favors the mobilization and metabolism of stored adipose tissue. It is possible that
mechanisms other than significant caloric deficit regulate systemic LRe concentrations in
morbidly obese females.
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Our results were limited by our subject drop out rate which affected our sample
size at 3 months post exercise. We also attempted to quantify pulmonary improvements in
gas diffusion through the VE/VCO2 slope and not with arterial gas sampling. The additions
of arterial gas concentrations may have aided in further understand why VE/VCO2 slopes
did not change in our group. Despite the challenges with arterial blood sampling, we may
have further explained the potential changes in exercise ventilation following RYGBS.
Lastly, we did not perform any baseline pulmonary tests which may have contributed to
our understanding of the potential pulmonary improvements observed post surgery.
In conclusion, we observed that ventilatory responses to exercise (VE/VCO2 slope)
were not improved 3-months post-GBS, even though truncal adiposity and serum leptin
were significantly reduced. Our results are in contrast to previous reports that adiposity
and basal leptin levels modify exercise ventilation in obesity. We also observed no
significant reductions in soluble leptin receptor and LRe which had previously been shown
to be increased during prolong nutritional deficits and weight loss, as is accomplished
following RYGBS. Lastly, it is possible that 3 months post surgery changes in adiposity
and serum leptin were not substantial enough for an improvement in ventilatory responses
during weight bearing exercise. Future research is needed to describe the pulmonary
differences between weight-bearing and non-weight bearing exercise in morbidly obese
females beyond the 3 month post-operative time point.
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Figures and Graphs
Table I. Anthropometrics measures obtained from morbidly obese females prior to, 1
month and 3 months following RYGBS.
Variable

Pre-Surgery

1 month Post-Surgery
(N=9)

(N=9)
Body weight (kg)
119.2 (±11.4)
Body Mass Index (kg/m2)
43.0 (±4.1)
Abdominal Girth (cm)
120.2 (±11.8)
Waist Girth (cm)
109.7 (±9.7)
Hip Girth (cm)
136.2 (±8.4)
Waist to Hip Ratio
0.808 (±0.1)
Total Fat (kg)
59.8 (±9.0)
Total Percent Fat
52.7 (±3.7)
Truncal Fat Mass (kg)
34.5 (±4.3)
Truncal Lean Mass (kg)
28.8 (±3.1)
Data presented as means ± standard derivations significant.
* Significantly different (p ≤ 0.05 ) than pre-surgery.

105.8 (12.5)
36.8 (4.7)*
113.2 (10.3)
104.9 (8.2)
128.0 (9.9)
0.824 (.01)
51.5 (±8.4)*
50.9 (2.4)*
29.0 (4.3)
27.1 (2.9)

3 month PostSurgery
(N=9)
96.2 (13.1)*
34.9 (4.2)*
105.4 (15.0)
96.5 (9.4)*
120.1 (±9.4)*
0.79 (0.1)
44.7 (±9.1)*
49.6 (4.2)*
24.6 (4.6)*
23.2 (2.5)*

Table II. Group cardiorespiratory measures obtained from morbidly obese females prior
to and 3 months following RYGBS.
Variable

Pre-Surgery
(N=9)

Total Exercise Duration (minutes)
13.8 (±2.8)
VO2max (L/min)
2.49 (±0.5)
21.1 (±4.8)
VO2max (ml/kg/min)
59.0 (±11.3)
VEmax (L/min)
Heart Rate Max (BPM)
173.6 (±15.0)
48.7 (±9.5)
VO2max (ml/kgffm/min)
1.03 (±0.1)
RERmax
2.12 (±.6)
VTmax (L/min)
21.6 (±2.4)
VE/VCO2 slope
Data presented as means ± standard derivations significant.
* Significantly different (p ≤ 0.05.) than pre-surgery.
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3 month
Post-Surgery
(N=9)
15.3 (±3.3)
2.28 (±0.3)
24.5 (±5.2)
58.6 (±5.7)
171.7 (±11.7)
47.8 (±8.4)
1.10 (±0.1)
2.09 (±.52)
22.01 (±3.4)

Figure I. Serum leptin concentrations obtained from morbidly obese females prior to, 1
month and 3 months following RYGBS.
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Figure II. Serum soluble leptin receptor (LRe) concentrations obtained from morbidly
obese females prior to, 1 month and 3 months following RYGBS.
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Figure III. Pre and 3 month post-surgery ventilatory response to exercise obtained from
morbidly obese females prior to and 3 months following RYGBS. Dark bar indicates
group means at pre-surgery and 3 months post-surgery.
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July 2005 to 2008







Research Assistant- Conduct clinical and performance based research with
faculty from the Department of Health and Human Performance. Perform full
range of independent research responsibilities; hypothesis development,
research design, informed consent, institutional review board, subject
recruitment, data collection, statistical analysis and critical results assessment.
Adjunct Faculty- Design and teach undergraduate courses in exercise physiology,
exercise physiology laboratory techniques, exercise testing and principles of
strength and conditioning. Design and conduct lectures and labs in the
fundamental concepts in the field of exercise physiology such as bioenergetics,
pulmonary respiration, muscular function and adaptations to exercise.
Human Performance Lab Coordinator- Work under the faculty lab director to
coordinate lab use and train faculty and staff on equipment procedures. Update
and maintain the lab equipment.
Mentor- Participate in a university undergraduate mentor program. Mentor an
undergraduate student seeking professional and academic growth within an
applied health sciences field.

James Madison University, Department of Kinesiology, Harrisonburg, VA
August 2002 to June 2005




Graduate Teaching Assistant- Developed and conducted lectures and labs to
educate undergraduate students in the topics of health, wellness and exercise
physiology. Designed and implemented educational labs to illustrate scientific
principles discussed in lecture to include: maximal oxygen uptake, exercise
effects on blood pressure, cardiac function, environmental stress and muscular
metabolism.
Graduate Research Coordinator- Worked under the primary investigator as
assistant research coordinator. Duties included managing subject recruitment,
research assistant scheduling and training, data collection coordination,
equipment management, staff training and statistical analysis of data.

Allez Training Systems, LLC, Richmond, VA
January 2003 to Present


President/Consultant- Prescribe custom sport performance training for
endurance athletes and teams. Work with amateur and professional cyclists,
runners and multi-sport athletes through goal development, periodization
training plans and sport specific training protocols. Lecture and consult with
teams and organizations on the topics of exercise physiology, exercise
prescription, athlete development and markers of training adaptation.

State of Maine Department of Mental Health, Portland, ME
March 1997-June 2002
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Licensed Social Worker- Provided outreach and counseling for chronic
mentally ill adults in the community. Primary job responsibilities included the
coordination and development of a community based rehabilitation program for
mentally ill adults. Duties involved: individual and group counseling sessions,
social services procurement, state disability funds management, locating and
securing housing, development of clinical rehabilitation team, substance abuse
counseling and functioning as lead coordinator within a diverse community-based
support team.

______________________________________________________________

Oral Research Presentations

Evans, RK, Bond, DS, Wolfe, LG, Meador, JG, Herrick, JE, Kellum, JM, Maher, JW.
(2007). Participation in 150 min/wk of moderate or higher intensity physical activity
yields greater weight loss after gastric bypass surgery. Presented at the American
Society for Metabolic and Bariatric Surgery annual meeting, October, 2007, San Diego,
CA.
Herrick, JE, Saunders, MJ, Wenos, DL. A physiological and performance comparison of
front and dual suspension mountain bicycles on rugged trail. Oral presentation at the
American College of Sport Medicne annual meeting, Nashville, TN, June 2005.

Research Poster Presentations
Blackwell, WM, Herrick, JE, Franco, RL, Lipford, GF, Wickham, EP, Evans, RK.
Relationships among serum leptin, body weight status, and cardiorespiratory fitness in
obese African-American adolescents enrolled in a weight management program. Poster
to be presented at the Southeast Chapter American College of Sport Medicine annual
conference, February, 2009, Birmingham, AL.
Vesely, SD, Franco, RL, Fallow, BA, Herrick, JE, Larson, NY, Arrowood, J, Evans, RK.
Assessment of changes in cardiorespiratory fitness parameters of morbidly obese
females following gastric bypass surgery. Poster to be presented at the Southeast
Chapter American College of Sport Medicine annual conference, February, 2009,
Birmingham, AL.
Herrick, JE, Evans, RK, Franco, RL, Stern, M, Bryan, DL, Larson, NY, Toderico, BJ,
Laver, JH. Improvements in blood lipid profile following a 6-month multi-disciplinary
adolescent healthy weight management program. Poster presented at the Southeast
Chapter American College of Sport Medicine annual conference, January, 2006,
Charlotte, NC.
Toderico, BJ, Evans, RK, Franco, RL, Stern, M, Bryan, DL, Larson, NY, Herrick, JE. The
T.E.E.N.S. Healthy Weight Management Program: Changes in physical fitness
characteristics of overweight adolescents after 6 months of participation. Poster
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presented at the Southeast Chapter American College of Sports Medicine annual
conference, January, 2006, Charlotte, NC.

Peer Reviewed Research Publications
Evans, RK, Franco, RL, Stern, M, Wickham, EP, Bryan, DL, Herrick, JE, Larson, NY,
Abell, AM, Laver, JH. (2008). Evaluation of a 6-month multi-disciplinary healthy weight
management program targeting urban, overweight adolescents: Effects on physical
fitness, physical activity, and blood lipid profiles. International Journal of Pediatric
Obesity. August 13:1-4.
Evans, RK, Bond, DS, Wolfe, LG, Meador, JG, Herrick, JE, Kellum, JM, Maher, JW.
(2007). Participation in 150 min/wk of moderate or higher intensity physical activity
yields greater weight loss after gastric bypass surgery. Surgery for Obesity and Related
Diseases. 3: 526-530.
Saunders, MJ, Luden, ND, Herrick, JE. (2007). Consumption of an oral carbohydrateprotein gel improves cycling endurance and prevents post-exercise muscle damage.
Journal of Strength and Conditioning Research. 21(3):678-84.
Saunders, MJ, Luden, ND, Herrick, JE, Hart, JE, Mishler, AE, Moore, RW. (2005). Effects
of a carbohydrate/protein gel on exercise performance in male and female cyclists.
Journal of the International Society of Sports Nutrition. 2(1):1-30.

Published Research Abstracts
Franco, RL, Evans, RK, Herrick, JE, Larson, NY, Abell, AM, Stern, M, Bryan, DL,
Wickham, EP, Laver, JH. (2007). Physical activity participation among overweight
adolescents with and without the metabolic syndrome. Medicine & Science in Sports &
Exercise. 39(5) Supplement: S239.
Herrick, JE, Saunders, MJ, Wenos, DL, Flohr, JA. (2006). Metabolic comparison of front
and full suspension mountain bicycles during simulated cross-country race conditions.
Medicine & Science in Sports & Exercise. 38(5) Supplement: S402-403.
Saunders, MJ, Todd, MK, Valentine, RJ, St.Laurent, TG, Kane, MD, Luden, ND, Herrick,
JE. (2006). Inter-study examination of physiological variables associated with improved
endurance performance with carbohydrate/protein administration. Medicine & Science
in Sports & Exercise. 38 (5) Supplement: S113-114.
Flohr, JA, Saunders, MJ, Evans, SW, St. Laurent, TG, Herrick, JE. (2005). The effect of
moderate intensity exercise on academic performance of children with ADHD. Medicine
& Science in Sports & Exercise. 37(5): Supplement: S274.
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Herrick, JE, Saunders, MJ, Wenos, DL. (2005). A physiological and performance
comparison of front and dual suspension mountain bicycles on rugged trail. Medicine &
Science in Sports & Exercise. 37(5): Supplement: S215-216.
____________________________________________________________________

Grants, Awards and Fellowships
Virginia Commonwealth University, Richmond, Virginia, August 2005 – May 2008.
School of Education research fellowship.
Cannondale Bicycle Inc. Bedford, Pennsylvania, June 2004. Research grant provided
$6000 in mountain bicycles for field based research project.
Massanutten Resorts, Mass Resorts Inc, McGayghesville, Virginia, June 2004. Research
grant provided land access permit for field based research project.
James Madison University, Harrisonburg, Virginia, August 2003 through August May 2005.
Graduate research assistantship.
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